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Abstract
The Food Quality Protection Act (FQPA) of 1996 requires the United States Environmental Protection Agency to
consider the cumulative effects of exposure to pesticides having a ‘common mechanism of toxicity.’ This paper reviews
the information available on the acute neurotoxicity and mechanisms of toxic action of pyrethroid insecticides in
mammals from the perspective of the ‘common mechanism’ statute of the FQPA. The principal effects of pyrethroids
as a class are various signs of excitatory neurotoxicity. Historically, pyrethroids were grouped into two subclasses
(Types I and II) based on chemical structure and the production of either the T (tremor) or CS (choreoathetosis with
salivation) intoxication syndrome following intravenous or intracerebral administration to rodents. Although this
classiﬁcation system is widely employed, it has several shortcomings for the identiﬁcation of common toxic effects. In
particular, it does not reﬂect the diversity of intoxication signs found following oral administration of various
pyrethroids. Pyrethroids act in vitro on a variety of putative biochemical and physiological target sites, four of which
merit consideration as sites of toxic action. Voltage-sensitive sodium channels, the sites of insecticidal action, are also
important target sites in mammals. Unlike insects, mammals have multiple sodium channel isoforms that vary in their
biophysical and pharmacological properties, including their differential sensitivity to pyrethroids. Pyrethroids also act
on some isoforms of voltage-sensitive calcium and chloride channels, and these effects may contribute to the toxicity
of some compounds. Effects on peripheral-type benzodiazepine receptors are unlikely to be a principal cause of
pyrethroid intoxication but may contribute to or enhance convulsions caused by actions at other target sites. In
contrast, other putative target sites that have been identiﬁed in vitro do not appear to play a major role in pyrethroid
intoxication. The diverse toxic actions and pharmacological effects of pyrethroids suggest that simple additivity
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models based on combined actions at a single target are not appropriate to assess the risks of cumulative exposure
to multiple pyrethroids. © 2002 Elsevier Science Ireland Ltd. All rights reserved.
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1. Introduction
The Food Quality Protection Act (FQPA) of
1996 dramatically altered the regulation of pesti-
cides in the United States. This Act, which
amended both the Federal Insecticide, Fungicide
and Rodenticide Act and the Federal Food, Drug
and Cosmetics Act, requires the United States
Environmental Protection Agency (EPA) to con-
sider a number of factors relative to the toxicol-
ogy of pesticides, including the cumulative effects
of exposure to pesticides having a ‘common mech-
anism of toxicity’. The methods for identifying
pesticides having a common mechanism of toxic-
ity, and the ramiﬁcations of such a determination,
are only now beginning to be clariﬁed.
Pyrethroids are a class of synthetic insecticides
that have been designed and optimized based on
the structures of the pyrethrins, the six insecticidal
constituents of the natural insecticide pyrethrum
(Elliott, 1995). Since the 1970s the pyrethroids
have been widely used to control insect pests in
agriculture and public health. By the mid-1990s,
pyrethroid use had grown to represent 23% of the
U.S. dollar value of the world insecticide market,
ranking second only to organophosphorus com-
pounds among insecticide classes (Casida and
Quistad, 1998).
This paper reviews the data available from the
published literature and from unpublished studies
by pyrethroid manufacturers on the toxicity and
mechanisms of toxic action of the pyrethroids in
mammals. Pyrethroids as a class are acute neuro-
toxicants, although some individual compounds
have been associated with the production of toxic
effects on other organ systems in long-term feed-
ing studies. In the context of the implementation
of the FQPA and the need to discern common
mechanisms of toxicity, this review therefore fo-
cuses on the neurotoxic actions of pyrethroids in
mammals. Other topics (e.g. insecticidal activity;
toxicokinetics and metabolism) are covered in less
detail and only as they relate to the principal
emphasis of this review. This document is in-
tended to serve as a contemporary review of the
state of the science in the ﬁeld of pyrethroid
neurotoxicology and to inform and aid the regula-
tory review of pyrethroids under the common
mechanism statute of the FQPA.
2. Structures and insecticidal properties of
pyrethroids
2.1. What is a pyrethroid?
The term ‘pyrethroid’ is commonly used to
designate a synthetic insecticide that is derived
structurally from the natural pyrethrins, the six
insecticidal constituents of pyrethrum extract
(Fig. 1). Decades of research and development by
the agrochemical industry and by government and
academic research laboratories have resulted in a
wide range of pyrethroid structures and a multi-
tude of uses in agricultural, veterinary, medical
and household pest control. The development of
synthetic pyrethroid insecticides has involved an
iterative process of structural modiﬁcation and
biological evaluation, so that the array of present-
day commercial and experimental insecticides
identiﬁed as ‘pyrethroids’ includes compounds
that are several conceptual steps removed from
the pyrethrins. In this review, we focus speciﬁcally
on pyrethrum (Fig. 1) and the following synthetic
pyrethroid insecticides that are registered for use
in the United States and many other parts
of the world, either as fully racemic mixtures,
mixtures of speciﬁed isomers, or single resolved
isomers (Fig. 2): allethrin (both bioallethrin and
S-bioallethrin), bifenthrin, cyﬂuthrin (including
beta-cyﬂuthrin), cyhalothrin (including lambda-
cyhalothrin), cypermethrin (including zeta-
cypermethrin), deltamethrin, fenpropathrin, fen-
valerate (including esfenvalerate), permethrin,D.M. Soderlund et al. / Toxicology 171 (2002) 3–59 5
Fig. 1. Structures of the six natural pyrethrins.
resmethrin, teﬂuthrin, tetramethrin, and
tralomethrin.
2.1.1. Deelopment of synthetic pyrethroids
The discovery and development of synthetic
pyrethroid insecticides has been the subject of
numerous reviews. The summary that follows is
based primarily on a recent comprehensive review
by Elliott (1995) and on earlier sources cited
therein.
The principal drawback of pyrethrum as an
insecticide is its instability in light and air, which
limits its effectiveness in crop protection and
other insect control contexts in which residual
activity is essential. The development of synthetic
pyrethroids is the result of efforts to modify the
structure of the natural pyrethrins (Fig. 1) in
order to increase photostability while retaining
the potent and rapid insecticidal activity and rela-
tively low acute mammalian toxicity of
pyrethrum. Most synthetic pyrethroids were dis-
covered by the sequential replacement of struc-
tural elements of the pyrethrins with novel
structural moieties that were selected to conserve
the molecular shape and physical properties of the
template structure. Because the pyrethrins are es-
ters of a cyclopropanecarboxylic acid and a cy-
clopentenolone alcohol (Fig. 1), synthetic
modiﬁcations typically held one of these major
domains of the molecule constant while introduc-
ing new structural features in the other. Although
the early stages of this process made reference to
the natural pyrethrins as templates, subsequent
stages employed newly discovered synthetic
pyrethroids with desirable insecticidal activity,
stability, and other properties as the templates for
the further design of new compounds.
Both the historical development of pyrethroids
as an insecticide class and the structural diversity
of pyrethroids are illustrated by the compounds
currently registered for use in the United States
(Fig. 2). Allethrin, one of the earliest of syntheticD
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Fig. 2. Structures of synthetic pyrethroids registered for use in the United States.D.M. Soderlund et al. / Toxicology 171 (2002) 3–59 7
pyrethroids still in current use, represents one
initial synthetic approach, the replacement of the
pentadienyl side chain of pyrethrin I with a sim-
pler, synthetically more accessible moiety having
similar steric and electronic properties. Other
early synthetic analogues were designed by replac-
ing the center of unsaturation represented by the
alkenyl side chain of the alcohol moieties of
pyrethrins and allethrin by an aromatic sub-
stituent. The next signiﬁcant step in pyrethroid
development involved the replacement of the cy-
clopentenolone ring of the pyrethrin and allethrin
alcohols with an alternative unsaturated hetero-
cyclic moiety, resulting in resmethrin (Fig. 2).
This compound not only exhibited increased pho-
tostability but also was substantially more potent
as an insecticide and lower in acute mammalian
toxicity than pyrethrin I. The combination of
these desirable properties in a single molecule
provided a strong impetus to search for new
compounds with greater activity and photostabil-
ity. Examples of other commercially important
pyrethroids that are cyclopropanecarboxylate es-
ters of modiﬁed alcohol moieties include te-
tramethrin, bifenthrin, and teﬂuthrin (Fig. 2).
Permethrin (Fig. 2) proved to be the ﬁrst syn-
thetic pyrethroid with sufﬁcient photostability for
agricultural use. When compared to resmethrin,
this compound contains structural replacements
in both the alcohol moiety (3-phenoxybenzyl for
5-benzyl-3-furylmethyl) and the acid moiety (chlo-
rines for methyl groups) that confers enhanced
photostability without loss of insecticidal activity.
Inclusion of a -cyano substituent in the 3-phe-
noxybenzyl alcohol moiety, as in deltamethrin
(Fig. 2), produced compounds with much greater
insecticidal potency than permethrin but with sim-
ilar photostability. Synthetic pyrethroids related
in structure to permethrin and deltamethrin,
which constitute the largest chemical subfamily of
pyrethroids in current use, include cypermethrin,
cyﬂuthrin, cyhalothrin, fenpropathrin and
tralomethrin (Fig. 2). These compounds exhibit
structural features that confer an expanded range
of insecticidal activity, enhanced overall insectici-
dal potency, modiﬁed photostability, or other de-
sirable properties when compared to pyrethrum
or earlier synthetic pyrethroids.
The structural diversity of synthetic pyrethroids
was further enhanced by the discovery that the
2,2-dimethylcyclopropanecarboxylic acid moiety
of the pyrethrins and most synthetic compounds
could be replaced by an -isopropylphenylacetic
acid moiety. This new series of compounds led to
the discovery of the commercial insecticide fen-
valerate (Fig. 2). More radical changes based on
this series included replacement of the central
ester bond with structures (e.g. etofenprox; see
Fig. 3) that retained the overall conﬁguration of
the molecule. These series yielded candidate com-
mercial insecticides with pyrethroid-like insectici-
dal activity, but examples of these compounds are
not registered for use in the United States.
2.1.2. Structure–actiity relationships for
insecticidal actiity
It is difﬁcult to identify a structural relationship
between compounds as diverse as the non-ester
pyrethroid etofenprox and pyrethrin I without
knowledge of the structures of the entire
pyrethroid series. Nevertheless, pyrethroids as di-
verse structurally as these two compounds con-
form to a single, operationally deﬁned
structure–activity relationship for insecticidal ac-
tivity that is based on the physical properties,
shape and three-dimensional conﬁguration of the
entire molecule (Elliott et al., 1974a). Fig. 3 iden-
tiﬁes the principal elements of the pyrethroid
structure–activity relationship and illustrates
these elements with four structurally divergent
pyrethroid insecticides. It is evident from this
analysis that there is no speciﬁc substructure,
reactive entity, or molecular moiety that can be
identiﬁed as the toxophore conferring pyrethroid-
like insecticidal activity. Instead, such activity ap-
parently results from the appropriate ﬁto ft h e
entire molecule at the site of action, and a wide
variety of chemical structures have been shown to
satisfy the requirements for ﬁt at that site based
on insecticidal activity data.
The signiﬁcance of overall molecular shape in
the action of pyrethroids is most clearly evident in
the stringent stereospeciﬁcity of insecticidal ac-
tion. The presence of two chiral centers at carbon-
1 and carbon-3 of the chrysanthemic acid moiety
of pyrethrin I produces two pairs ofD.M. Soderlund et al. / Toxicology 171 (2002) 3–59 8
Fig. 3. Essential features of pyrethroid structure–activity relationships illustrated by pyrethrin I and three synthetic pyrethroids.
diastereomers, which are designated trans and cis
based on the orientation of the C-1 and C-3
substituents in relation to the plane of the cyclo-
propane ring (Fig. 4). The acid moieties of the
natural pyrethrins are exclusively in the 1R,trans
conﬁguration. When esters were prepared from
the four resolved chrysanthemic acid isomers,
those with the R conﬁguration at cyclopropane
C-1 were insecticidal, whereas the enantiomeric
1S compounds, though physically identical, were
without insecticidal activity (Elliott et al., 1974a).
This profound stereospeciﬁcity extends to com-
pounds such as fenvalerate, in which the 2S
conﬁguration of the non-cyclopropane acid moi-
ety is structurally congruent with 1R cyclo-
propanecarboxylates and gives insecticidal esters,
whereas the corresponding 2R esters are inactive
(Fig. 4). Stereospeciﬁc determinants of insecticidal
activity are implicit even in achiral acid moieties,
such as 2,2,3,3-tetramethylcyclopropanecarboxylic
acid, the acid moiety of the insecticide fen-
propathrin. Removal of one methyl group from
this symmetrical acid creates a chiral cyclo-
propanecarboxylate that obeys the same struc-
ture–activity rules as those elaborated for
chrysanthemic acid isomers (Elliott et al., 1974a).
Stereoisomerism is a less common feature of
pyrethroid alcohol moieties. Nevertheless, when aD.M. Soderlund et al. / Toxicology 171 (2002) 3–59 9
chiral center is present in the alcohol moiety at
the carbon bearing the hydroxyl group (e.g. al-
lethrin and deltamethrin; see Fig. 2), only one
epimer has high insecticidal activity even when
esteriﬁed to an acid moiety that contains the
appropriate stereochemical conﬁguration for high
insecticidal activity.
2.2. Mechanism of insecticidal action
Pyrethroids are known to alter the normal
function of insect nerves by modifying the kinetics
of voltage-sensitive sodium channels, which medi-
ate the transient increase in the sodium permeabil-
ity of the nerve membrane that underlies the nerve
action potential (Soderlund and Bloomquist,
1989; Bloomquist, 1993a). The action of
pyrethroids on insect and other invertebrate
sodium channels, and the correlation of these
effects with insecticidal activity, has been reviewed
extensively (Sattelle and Yamamoto, 1988; Soder-
lund and Bloomquist, 1989; Narahashi, 1992;
Bloomquist, 1993a; Soderlund, 1995; Narahashi,
1996). A more detailed summary of the actions of
pyrethroids on sodium channels will be presented
in a subsequent section of this review.
Conﬁrmation that voltage-sensitive sodium
channels are the principal sites of insecticidal ac-
tion of pyrethroids has emerged from studies of
the molecular genetics of mechanisms of
pyrethroid resistance that involve reduced nerve
sensitivity (Soderlund, 1997; Soderlund and Knip-
ple, 1999). In the houseﬂy, the kdr (‘knockdown
resistance’) and super-kdr (enhanced knockdown
resistance) traits confer resistance to all
pyrethroids by reducing the sensitivity of the ﬂy
nervous system to these compounds. Genetic link-
age analyses mapped these traits close to the
principal voltage-sensitive sodium channel gene of
the houseﬂy (designated Vssc1). Moreover, kdr-
like resistance in other insect species has been
mapped to sodium channel genes that are or-
thologous to Vssc1. DNA sequence analyses of
Vssc1 coding sequences from susceptible and re-
sistant houseﬂy strains identiﬁed a single mutation
common to all resistant strains and a second
mutation found only in the highly-resistant super-
kdr strains. Insertion of these mutations into a
susceptible Vssc1 cDNA, followed by functional
analysis of the susceptible and speciﬁcally mu-
tated sodium channels, showed that these muta-
tions were sufﬁcient to account for the resistance
caused by the kdr and super-kdr traits. Therefore,
the sodium channels encoded by the Vssc1 gene of
the houseﬂy and by orthologous genes of other
insect species must be the principal sites of insecti-
cidal action of pyrethroids.
An unanticipated ﬁnding from these molecular
genetic studies was the insensitivity to pyrethroids
of sodium channels containing the two mutations
associated with the super-kdr resistance trait (Lee
et al., 1999; Lee and Soderlund, 2001). It remains
to be determined whether sodium channels from
super-kdr insects, when assayed in their native
neuronal environment, are equally insensitive to
pyrethroids. If the insensitivity of expressed chan-
nels is conﬁrmed in assays with native neuronal
preparations, then the modest but clearly demon-
strable toxicity of pyrethroids to super-kdr insects
may involve one or more target sites other than
the voltage-sensitive sodium channel encoded by
the Vssc1 gene.
Fig. 4. Stereochemical determinants of insecticidal activity in
pyrethroid acid moieties.D.M. Soderlund et al. / Toxicology 171 (2002) 3–59 10
3. Mammalian toxicity
3.1. Acute toxicity
3.1.1. Acute toxicity to mammals
Prior to 1970, there was little available informa-
tion on the acute toxicity to mammals of the
natural pyrethrins or the limited group of syn-
thetic pyrethroids known at that time. The ﬁrst
systematic study of pyrethroid toxicity (Ver-
schoyle and Barnes, 1972) compared the acute
oral and intravenous toxicities to rats of
pyrethrum, pyrethrin I, pyrethrin II, bioallethrin,
isomers and isomer mixtures of resmethrin, and a
structural relative of resmethrin. This study docu-
mented the modest oral toxicity of the tested
compounds, the signiﬁcant intravenous toxicity of
the pyrethrins and bioallethrin, and the profound
differences in the toxicity of resmethrin isomers
by both routes of administration.
The discovery during the 1970s of numerous
new pyrethroids with the potential for widespread
use in agriculture stimulated more extensive stud-
ies of pyrethroid toxicity both in the context of
academic research and in support of the registra-
tion of insecticide products. As a result, there now
exists a large and diverse set of data on the acute
toxicity of pyrethroids to mammals by routes of
administration relevant to human exposure (e.g.
oral) as well as routes (e.g. intravenous, intraperi-
toneal, intracerebral) not directly relevant to hu-
man exposure but instead chosen for the precise
experimental manipulation of dose and the direct
delivery of toxicant to the presumed target organ.
Table 1 summarizes the oral toxicity to rats of
several pyrethroids that are currently registered
for use in the United States. With few exceptions,
these compounds have acute oral LD50 values
following administration in vegetable oils lying
between 50 and 500 mg/kg and are therefore
considered to be moderately toxic (EPA Category
II). As illustrated in Table 1, the acute oral toxic-
ity of any pyrethroid varies widely depending on
the administration vehicle used. In contrast to the
moderate oral toxicity of most pyrethroids, the
pyrethroids as a class exhibit very low levels of
systemic toxicity following dermal exposure
(Clark, 1995).
3.1.2. Structure–toxicity relationships
Determination of the acute toxicity of the re-
solved optical isomers of several pyrethroids fol-
lowing intravenous administration to rats
(Verschoyle and Aldridge, 1980) and intracerebral
administration to mice (Lawrence and Casida,
1982) permitted the elucidation of structure–ac-
tivity relationships for acute mammalian toxicity.
The principal features of these relationships, sum-
marized below, are drawn from a more detailed
analysis published elsewhere (Gray and Soder-
lund, 1985).
The neurotoxicity of pyrethroids to mammals
depends on the stereochemical conﬁguration at
cyclopropane C-1 or the homologous position in
compounds lacking the cyclopropanecarboxylate
moiety (see Fig. 4). Only esters of 1R cyclo-
propanecarboxylates and isosteric 2S isomers of
non-cyclopropane acids are neurotoxic, whereas
the corresponding 1S cyclopropanecarboxylates
and their sterically equivalent 2R acyclic analogs
are without measurable toxicity even when admin-
istered at high doses directly to the CNS (Gray
and Soderlund, 1985). This relationship parallels
the stereospeciﬁcity of insecticidal action of
pyrethroids (see Section 2.1.2).
In mammals, the absolute conﬁguration at cy-
clopropane C-3 of cyclopropanecarboxylate esters
of primary alcohols (e.g. resmethrin, permethrin)
also strongly inﬂuences toxicity (Table 2). Typi-
cally, pyrethroids from this group of compounds
having the 1R,cis conﬁguration (e.g. [1R,cis]-per-
methrin and NRDC 157, Table 2) are both insec-
ticidal and toxic to mammals, whereas the
corresponding pyrethroids having the 1R,trans
conﬁguration (e.g. [1R,trans]-permethrin, Table
2), though similar in insecticidal potency, lack
measurable acute toxicity to mammals. Initially,
the low toxicity of these 1R,trans compounds to
mammals was ascribed to their rapid hydrolytic
detoxication by liver esterases (see Section 4.3),
but intracerebral dosing experiments (Lawrence
and Casida, 1982) demonstrated that these com-
pounds had very low intrinsic toxicities even when
the impact of biotransformation was removed.
This dependence of the acute toxicity of cyclo-
propanecarboxylate esters of primary alcohols on
stereochemical conﬁguration at C-3 is generallyD.M. Soderlund et al. / Toxicology 171 (2002) 3–59 11
Table 1
Acute oral toxicities of pyrethroids to rats
LD50 (mg/kg) Reference Compound Straina Vehicle
Female Male
410 Bioallethrin (Furnax and Audegond, 1985a) S Corn oil 395
(Furnax and Audegond, 1985b) S-Bioallethrin S 320 Corn oil 370
53.8 Bifenthrin S Corn oil (Freeman, 1982) 70.1
(Southwood, 1985a) Lambda-cyhalothrin A 56 Corn oil 79
299 433 Aqueous (Allen and Leah, 1990)
suspensionb
Cyﬂuthrin (Heimann, 1987) W 160 Acetone+peanut oil 155
372 Cypermethrin (Freeman, 1987) S Corn oil 297
(Rand, 1983) 7180 Undiluted 7654
86 Zeta-cypermethrin (Freeman, 1989) S Corn oil 134
Deltamethrin (Varsho, 1996) S8 7 Corn oil 95
Aqueous (Myer, 1989) 5000 5000
suspensionc
(Hiromori et al., 1983) Fenpropathrin S 66.7 Corn oil 70.6
370d Fenvalerate (Bilsback et al., 1984) S Corn oil 370d
Esfenvalerate (Bilsback et al., 1984) S8 7
e Corn oil 87
e
1200
e Permethrin (Killeen, 1975) W Corn oil 1200
e
(Killeen, 1975) 8900
e Undiluted 8900
e
320 Pyrethrum (Gabriel, 1992) S Corn oil 710
(Glomot, 1979) Resmethrin S 1640 Corn oil 1695
(Southwood, 1985b) Teﬂuthrin A Corn oil 21.8 34.6
(Audegond et al., 1981a) Tralomethrin S 157 Sesame oil 99
Aqueous (Audegond et al., 1981b) 1000 and 1000 and
suspensionf 5000 5000
a Strain: A, Alderley Park; S, Sprague–Dawley; W, Wistar.
b Containing 0.5% hydroxypropylmethylcellulose+0.1% polysorbate 80.
c Containing 1% methylcellulose.
d Exact LD50 not calculated; mortality less at higher doses.
e Combined value for males and females.
f Containing 0.25% carboxymethylcellulose+0.2% polysorbate 80.
applicable to this class, but two signiﬁcant excep-
tions are known: [1R,cis]-phenothrin lacks mea-
surable toxicity to mammals (see Table 2),
whereas [1R,trans]-ethanomethrin
1 (a close struc-
tural relative of bioresmethrin) is a potent central
neurotoxicant in mammals (Lawrence and Casida,
1982).
In mammals, as in insects, the presence of an
-cyano substituent in S conﬁguration in the 3-
phenoxybenzyl alcohol moiety also greatly en-
hances acute neurotoxicity. In the case of
mammalian toxicity, this effect is highly
stereospeciﬁc: the -R epimers of compounds that
retain the appropriate conﬁgurations for high tox-
icity in the acid moiety have no demonstrable
toxicity when injected directly into the brain (e.g.
NRDC 156B, Table 2). The -cyano substituent
also indirectly alters structure–toxicity relation-
ships in the acid moiety. The most dramatic ef-
fects are seen with the 1R,trans cyclopropane-
carboxylates of 3-phenoxybenzyl alcohol (e.g.
[1R,trans]-permethrin, Table 2), which exhibit ex-
tremely low toxicity to mammals; addition
of an -cyano substituent in the S conﬁguration
to these esters produces compounds (e.g.
1 5-Benzyl-3-furylmethyl-3-cyclopentylidenemethyl-2,2-di-
methylcyclopropanecarboxylate, also designated RU 11679.D.M. Soderlund et al. / Toxicology 171 (2002) 3–59 12
Table 2
Effects of pyrethroid structure and stereochemistry on intracerebral acute toxicity to mice
Name or designation X Isomer LD50 (g/g brain)a R
8600 Phenothrin H CH3 trans
H Phenothrin CH3 4300 cis
860 Permethrin C1 trans H
Permethrin 11 C1 H cis
H NRDC 157 5.4b Br cis
12 Cyphenothrin CH3 trans S-CN
Cyphenothrin 3.9 CH3 S-CN cis
1.6 Cypermethrin C1 trans S-CN
0.6 Cypermethrin C1 cis S-CN
De tamethrin 0.5, 1.2 Br S-CN cis
R-CN NRDC 156B Br 860
b cis
a Data from Lawrence and Casida (1982) except were noted.
b Data from Ghiasuddin and Soderlund (1985), recalculated on the basis of g/g brain weight.
[1R,trans,S]-cypermethrin, Table 2) with signiﬁ-
cant neurotoxicity to rodents.
These results demonstrate that, whereas
pyrethroid structure–toxicity relationships in
mammals are generally congruent with structure–
activity relationships in insects, there are never-
theless signiﬁcant differences. These differences, as
well as the individual compounds noted above
that are exceptions to the general structure–activ-
ity rules, underscore the risks of generalizing
mammalian structure–toxicity relationships be-
yond compounds for which direct comparative
data exist.
Available structure–toxicity data show that
acute toxicity of pyrethroids to mammals depends
on the shape and three-dimensional conﬁguration
of the entire molecule. The absence of any
single structural feature or reactive moiety that is
required to produce pyrethroid-like toxicity im-
plies that there is no common toxophore that
mediates the acute toxicity of pyrethroids to
mammals.
3.2. Signs of pyrethroid intoxication
Two studies published in the early 1970s iden-
tiﬁed two distinct syndromes associated with the
acute toxicity of pyrethroids to rats. Verschoyle
and Barnes (1972) provided the ﬁrst systematic
description of the signs of pyrethroid intoxication
in rats following oral and intravenous dosing.
These authors noted the same syndrome of intox-
ication for pyrethrins, bioallethrin, resmethrin,
and NRDC 108
2 (an experimental pyrethroid
structurally related to resmethrin) by either route
of administration. This syndrome included hyper-
sensitivity and aggression followed by stimulus-in-
duced bouts of general tremor, convulsive
twitching, coma, and death. The principal differ-
ence observed between oral and intravenous dos-
ing was the speed of onset of intoxication.
2 5-Benzyl-3-furylmethyl-2,2,3,3-tetramethylcyclopropane-
carboxylate.D.M. Soderlund et al. / Toxicology 171 (2002) 3–59 13
The publication of the discovery of deltamethrin
(Elliott et al., 1974b), the ﬁrst pyrethroid contain-
ing the -cyano-3-phenoxybenzyl moiety, was ac-
companied by a brief report describing the acute
toxicity of deltamethrin to rats (Barnes and Ver-
schoyle, 1974). This report noted that the signs of
deltamethrin intoxication following either oral or
intravenous administration, which involved saliva-
tion without lacrimation followed by jerking leg
movements and progressive writhing convulsions
(choreoathetosis), were distinctly different than
those reported by these authors for other
pyrethroids (Verschoyle and Barnes, 1972). Inter-
estingly, the signs of deltamethrin intoxication in
freely-moving rats following direct infusion into
three different regions of the central nervous sys-
tem (lateral ventricle, cisterna magna, or sub-
arachnoid space) produced signs of intoxication
speciﬁc to each site of administration that were
not observed following intravenous administration
(Brodie, 1985). Whereas region-speciﬁc infusion
also produced some of the motor signs typical of
deltamethrin intoxication by other routes, admin-
istration of deltamethrin by these routes failed to
produce either choreoathetosis or salivation.
These results suggest that multiple target tissues or
regions of the central nervous system are involved
in producing the signs of toxicity observed follow-
ing intravenous administration and suggest that
the signs associated with deltamethrin intoxication
may be route-dependent.
A landmark study (Verschoyle and Aldridge,
1980) described both the acute toxicity and the
signs of intoxication of 36 pyrethroids following
intravenous administration, thereby establishing a
taxonomy of pyrethroid intoxication in mammals
that persists to the present. Of the 18 esters of
various primary alcohols examined in this study,
15 compounds produced signs of intoxication cor-
responding to those ﬁrst described for pyrethrins
and pyrethroids (Verschoyle and Barnes, 1972),
which was designated the T (tremor) syndrome,
whereas the remaining three compounds did not
produce any detectable signs of intoxication at the
highest doses tested. Of the 17 esters of -cyano-3-
phenoxybenzyl alcohol examined, 12 produced
signs of intoxication like those ﬁrst described for
deltamethrin (Barnes and Verschoyle, 1974),
which was designated the CS (choreoathetosis
with salivation) syndrome, whereas four produced
the T syndrome of intoxication. One -cyano-3-
phenoxybenzyl ester and one compound in which
the -cyano group was replaced by an -ethynyl
group were found to produce elements of both
syndromes (tremor with salivation). This classiﬁ-
cation of the signs of pyrethroid intoxication into
two principal syndromes was conﬁrmed in studies
of the intracerebral toxicity of 29 pyrethroids to
mice (Lawrence and Casida, 1982). The major
difference in the ﬁndings of these two studies was
that fenpropathrin, classiﬁed as a T syndrome
compound in the ﬁrst study, was classiﬁed as
exhibiting both syndromes of intoxication in the
second study.
An alternative nomenclature (Types I and II)
has been proposed for subgroups of pyrethroids
based not only on the syndromes of intoxication
produced in mammals (Lawrence and Casida,
1982) but also on their chemical structures, their
signs of poisoning in insects and their actions on
insect nerve preparations (Gammon et al., 1981).
The Type I/II nomenclature has been widely
adopted in the literature and is often used in a
manner parallel to the T/CS nomenclature, so that
Type I compounds are generally considered to
produce the T syndrome of intoxication and Type
II compounds are considered to produce the CS
syndrome (Lawrence and Casida, 1982). However,
we have chosen to employ the T/CS nomenclature
in this review because it reﬂects the historic clas-
siﬁcation of pyrethroid action in terms most
clearly related to the mammalian toxicology of
these compounds.
Although these studies provide an important
conceptual framework for interpreting the toxic
actions of pyrethroids in mammals, they are not
comprehensive from the perspective of compounds
currently registered for use. Of the 14 registered
pyrethroid structures speciﬁcally considered
in this review, pyrethrins and eight synthetic
pyrethroids (allethrin, cypermethrin, deltamethrin,
fenvalerate, fenpropathrin, permethrin, res-
methrin, and tetramethrin) were included in at
least one of the original comparative studies and
therefore could be considered to be classiﬁed in
terms of intoxication syndrome within the T/CS
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registered compounds (bifenthrin, cyﬂuthrin, cy-
halothrin, teﬂuthrin, and tralomethrin) were not
included in either study. Therefore, their tentative
inclusion in the T/CS classiﬁcation scheme must
be based on studies done in other laboratories by
methods other than those used in the two studies
that generated the classiﬁcation of syndromes.
Given that the primary classiﬁcation study (Ver-
schoyle and Aldridge, 1980) did not describe a
simple relationship between pyrethroid structure
and intoxication syndrome and also identiﬁed
some compounds with signs of intoxication that
did not fall neatly into either the T or CS class,
any assumptions about intoxication syndrome
produced by compounds other than those con-
tained in the two canonical classiﬁcation studies
must be made with great caution. Moreover, both
studies on which the classiﬁcation of symptoms is
based employed routes of administration (intra-
venous or intracerebral) that are not relevant to
routes of human exposure. Although the initial
descriptions of the T and CS syndromes suggested
that the signs of intoxication were independent of
the route of administration (Verschoyle and
Barnes, 1972; Verschoyle and Aldridge, 1980), it is
not clear from the available data that this general-
ization extends to all pyrethroids or to all routes
of administration. Without a corresponding data
set on the signs of intoxication following oral
administration under comparable experimental
conditions, any assumptions about the universal-
ity of the T/CS classiﬁcation scheme for all routes
of exposure must also be made with caution.
3.3. Behaioral assessments of pyrethroid
neurotoxicity
3.3.1. Regulatory neurotoxicity studies:
background and methodology
Acute and subchronic adult neurotoxicity
screening studies, conducted in accordance with
the regulatory guidelines
3 provided by the U.S.
EPA, represent a potential source of additional
information about the actions of the pyrethroids
that are currently registered for use in the U.S. As
a screen for neurotoxicity, these studies rely on
neurobehavioral tests that include clinical obser-
vations, a procedurally standardized functional
observational battery (FOB), measurements of
motor activity in an automated device, and termi-
nal microscopic examination of neural tissues. In
acute studies, the FOB and motor activity tests
are performed at least four times: prior to treat-
ment, at the time of peak effects (when signs of
intoxication are most pronounced, determined for
each compound in a preliminary range-ﬁnding
study) following the administration of a single
dose, and again 7 and 14 days following treat-
ment. In subchronic studies, animals are also
tested on four occasions: prior to the initiation of
treatment and again during weeks 4, 8 and 13 of
sustained treatment. Animals are also evaluated
for clinical signs of intoxication by cage-side ob-
servations that are performed at least once daily
for acute studies and once weekly for the sub-
chronic studies.
The regulatory neurotoxicity studies summa-
rized here were performed in several different
laboratories, using similar, but not identical, pro-
cedures. The FOB used in each of these studies is
based on the procedure described by Moser
(1989), in which the observer was blind with
respect to the animal’s dose group assignment to
ensure an unbiased assessment. The FOB begins
with cage-side observations that are conducted
prior to disturbing the animal and then continues
with a detailed physical examination. Next, the
animal is placed into an open ﬁeld to facilitate
observations including gait, activity level, posture,
and any unusual behaviors. At the end of this
period, the reaction to various stimuli is evalu-
ated, along with assessments of pupil size, pupil
response, and aerial righting. The FOB typically
concludes with measurements of grip strength,
landing foot splay, and body weight. Laboratories
are required to establish the adequacy of observer
training using reference compounds as positive
controls for the production of well-deﬁned effects.
It is also necessary to control inter-observer varia-
tion if there is more than one observer for a given
study. Thus, the standardized procedures em-
ployed in these tests offer the potential for signiﬁ-
3 U.S. Environmental Protection Agency, Ofﬁce of Pesti-
cides and Toxic Substances, Health Effects Test Guideline
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cant comparability across studies and provide
added conﬁdence in the accuracy and consistency
of the observations when compared to more rou-
tine cage-side observations.
The experimental design for the acute neurotox-
icity study is the most comparable of all studies
performed under regulatory guidelines to the pub-
lished studies that established the classical syn-
dromes of pyrethroid intoxication (Verschoyle
and Aldridge, 1980; Lawrence and Casida, 1982).
In acute neurotoxicity studies, the animals are
tested using the FOB at the time of peak effects,
when clinical signs of toxicity are most apparent.
The highest dose tested is one that produces clear
evidence of toxicity, i.e. approximately the highest
dose that animals are expected to survive. One
important difference between such studies and the
previous studies that established the taxonomy of
pyrethroid intoxication is the route of administra-
tion. For all of the examples summarized here, the
pyrethroid was administered orally, by gavage,
rather than by the intravenous (Verschoyle and
Aldridge, 1980) or intracerebral (Lawrence and
Casida, 1982) route.
The study design for the subchronic neurotoxic-
ity study is less comparable to the published
studies that deﬁned pyrethroid intoxication syn-
dromes (Verschoyle and Aldridge, 1980; Lawrence
and Casida, 1982) because the dose is adminis-
tered through the diet for an extended period (13
weeks). However, comparison among subchronic
studies is facilitated by the consistent use of di-
etary administration over an extended period.
With sustained dietary exposure, the peak concen-
trations of pyrethroid in target neural tissues may
be much lower, as the animal consumes the
treated feed ad libitum over the course of each
day. Furthermore, administration may be self-lim-
iting, as the animal may eat less treated feed if the
exposure produces systemic toxicity.
It is important to determine whether the results
of regulatory neurotoxicity studies identify syn-
dromes of pyrethroid intoxication that are consis-
tent with those described following intravenous
administration in the same species (Verschoyle
and Aldridge, 1980). One problem encountered in
such comparisons is the need to normalize de-
scriptions of the signs of intoxication observed
following intravenous administration (Verschoyle
and Aldridge, 1980) with those recorded in the
FOB employed in regulatory neurotoxicity stud-
ies. For example, the observation of ‘abnormal
hindlimb locomotion’ associated with the CS syn-
drome (Verschoyle and Aldridge, 1980) is too
vague to be correlated with speciﬁc responses
recorded from the FOB. However, because others
have described hindlimb impairment with
deltamethrin as increased hindlimb extensor tone
(Ray, 1982b) or splayed hindlimbs (Gray and
Rickard, 1982), evidence of hindlimb impairment
in regulatory neurotoxicity studies that involves
similar changes in posture (splayed hindlimbs or
hunched posture) and gait (exaggerated hindlimb
ﬂexion or hindlimbs splayed or dragging) may be
considered to be consistent with the CS syndrome.
On the other hand, distinctions between the T and
CS syndromes based on an increased response to
stimuli (increased sensitivity to stimuli with the T
syndrome and increased startle response with the
CS syndrome), and tremors (ﬁne or coarse) (Ver-
schoyle and Aldridge, 1980) are insufﬁciently clear
to permit their correlation with observations
recorded in the FOB employed in regulatory
studies.
3.3.2. Regulatory neurotoxicity studies: results
Of the pyrethroids that are registered for use in
the U.S., acute regulatory neurotoxicity study re-
sults are available for nine: four esters of primary
alcohols (bifenthrin, S-bioallethrin, permethrin,
and pyrethrum) and ﬁve compounds with an -
cyanophenoxybenzyl moiety (beta-cyﬂuthrin,
lambda-cyhalothrin, cypermethrin, zeta-cyperme-
thrin and deltamethrin). In these studies the ef-
fects of pyrethroids were transient, with peak
effects observed within hours of exposure and full
recovery within 1–14 days after treatment. Re-
sults of subchronic neurotoxicity studies are also
available for six of the compounds that were
examined in acute studies: bifenthrin, beta-
cyﬂuthrin, cypermethrin, zeta-cypermethrin,
deltamethrin, and permethrin. In these studies,
which involved dietary exposure ad libitum, the
signs of pyrethroid intoxication generally per-
sisted, but did not become more pronounced, with
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Table 3
Agreement of regulatory acute neurotoxicology studies with syndromes of pyrethroid intoxication: non-cyano pyrethroids
S-Bioallethrin (90) Permethrin (150) Pyrethroid dose (mg/kg) Pyrethrum (200) Bifenthrin (75)
T-syndrome
–– –a – Aggressive sparring
– +
b Increased sensitivity to stimuli + –
?? ?
c ? Fine tremor
– Prostration –– –
+ – – + Hyperthermia
CS-syndrome
–– –– Pawing and burrowing
Salivation – – ++
?c ?
c ?
c ?
c Coarse tremor
– Choreoathetosis –– –
Clonic seizures + – + –
++ ++ Abnormal hindlimb locomotion
–– Hypothermia – –
Based on syndromes described by Verschoyle and Aldridge (1980).
a Not present.
b Present.
c The observations from these studies do not distinguish between ﬁne and coarse tremor.
The results obtained for these nine compounds
are summarized in the following sections. The
signs of intoxication, obtained from both acute
and subchronic studies, are grouped in Tables 3
and 4 to indicate those consistent with the original
description of the T syndrome of intoxication and
those consistent with the original description of
the CS syndrome. In the case of permethrin and
cypermethrin, the results of a published neurobe-
havioral assessment in Long-Evans rats using a
protocol similar to the FOB employed in regula-
tory studies (McDaniel and Moser, 1993) are
included for comparison in the discussion below
but are not incorporated into the comparisons
presented in Tables 3 and 4.
3.3.2.1. Bifenthrin. In the acute neurotoxicity
study of bifenthrin (Watt, 1998a), the FOB was
performed at the time of peak effects, approxi-
mately 6–8 h following the administration of 10,
35 or 75 mg/kg of the undiluted compound to
male and female Sprague–Dawley rats. At the
highest dose, bifenthrin caused whole-body
tremors, twitching, staggered gait, uncoordinated
movement/ataxia, splayed hindlimbs, abnormal
posture, clonic convulsions, and abdominogenital
staining. No effects were evident at the two lower
doses. In the subchronic study (Freeman, 1998),
bifenthrin was administered via the diet to male
and female Sprague–Dawley rats at dietary con-
centrations of 50, 100 or 200 ppm (3, 7 and 13
mg/kg per day, respectively). At the two higher
dietary levels, bifenthrin produced whole-body
tremors, twitching, decreased grip strength and
increased landing foot splay. Effects were not
evident at the lowest dietary concentration.
Bifenthrin, a pyrethroid with a unique non-cy-
ano alcohol moiety (Fig. 2), was not included in
either of the original studies that established the
T/CS classiﬁcation of pyrethroid intoxication syn-
dromes. The production of tremors in both acute
and subchronic neurotoxicity does not assist the
classiﬁcation of bifenthrin because the results
recorded in the FOB do not indicate whether the
tremors were ﬁne or coarse. Other effects of bifen-
thrin in these studies (e.g. splayed hindlimbs and
convulsions) are associated more closely with the
CS syndrome of intoxication, an unexpected re-
sult for a pyrethroid that lacks the -cyano-3-phe-
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Table 4
Agreement of regulatory acute neurotoxicology studies with syndromes of pyrethroid intoxication: -cyano pyrethroids
Pyrethroid dose (mg/kg) Lambda-cyhalothrin Deltamethrin Cypermethrin Zeta-cypermethrin Beta-cyﬂuthrin
(35) (10) (100) (50) (50)
T-Syndrome
–– Aggressive sparring – –a –
–– – – Increased sensitivity to +
b
stimuli
Fine tremor – – ?c ?
c ?
c
–– –– Prostration –
Hyperthermia – –– – –
CS-Syndrome
– Pawing and burrowing – + ––
– + + – Salivation +
– Coarse tremor – ?
c ?
c ?
c
Cheoreoathetosis + –– –+
–– ++ Clonic seizures –
–– Abnormal hindlimb ++ +
locomotion
–– –+ Hypothermia +
Based on syndromes described by Verschoyle and Aldridge (1980).
a Not present.
b Present.
c The observations from these studies do not distinguish between ﬁne and coarse tremor.
3.3.2.2. S-Bioallethrin. For the acute neurotoxicity
study of S-bioallethrin (Broadmeadow, 1997), the
FOB was performed approximately 30–60 min
after the administration of 5, 30 or 90 mg/kg in
corn oil to male and female Sprague–Dawley
rats. At the highest dose, S-bioallethrin produced
tremor, hyperthermia, hunched posture, immobil-
ity, head and/or body twitches (myoclonus), un-
steady or crawling gait with splaying of the
hindlimbs, decreased landing foot splay and de-
creased grip strength. Lower doses produced no
effects in either sex.
Bioallethrin (a mixture of S-bioallethrin and its
-R epimer) was one of the compounds employed
in the initial description of the T syndrome of
pyrethroid intoxication following intravenous or
oral administration to rats (Verschoyle and
Barnes, 1972) and was also classiﬁed as a Type I
(T syndrome) compound upon intracerebral ad-
ministration to mice (Lawrence and Casida,
1982). In contrast, the results of the acute neuro-
toxicity study suggest a mixture of intoxication
signs that contains elements that are consistent
with both the T and CS syndromes of intoxica-
tion. The tremor and hyperthermia produced by
S-bioallethrin are consistent with the T syndrome
of intoxication, whereas the myoclonus, hunched
posture and splayed hindlimbs are consistent with
effects ascribed to the CS syndrome.
3.3.2.3. Beta-cyﬂuthrin. For the acute neurotoxic-
ity study of beta-cyﬂuthrin (Sheets et al., 1997),
the FOB was performed approximately 3 h fol-
lowing the administration of 0.5, 2.0 or 10 mg/kg
of beta-cyﬂuthrin in Cremophor to male and fe-
male Fischer 344 rats. In rats that received the 10
mg/kg dose, beta-cyﬂuthrin produced salivation,
hypothermia, repetitive chewing and pawing
movements, gait incoordination, a ﬂattened pos-
ture, choreoathetosis, muscle fasciculations, de-
creased activity, impaired aerial righting, and
decreased response to stimuli. Effects at the next
lower dose were limited to a decreased approach
response, clear oral stain and decreased activity.
No effects were evident at the lowest dose of 0.5
mg/kg. In the subchronic study (Sheets and
Hamilton, 1997), beta-cyﬂuthrin was administered
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concentrations of 30, 125 and 400 ppm (2, 9 and
29 mg/kg per day, respectively). At the 400 ppm
dietary level, beta-cyﬂuthrin caused gait incoordi-
nation, repetitive chewing movements, hypother-
mia, increased reaction to stimuli, impaired aerial
righting, and decreased grip strength. No effects
were evident at lower dietary concentrations.
Neither cyﬂuthrin nor beta-cyﬂuthrin were in-
cluded in the group of compounds forming the
basis of the T/CS classiﬁcation of intoxication
syndromes. However, as a member of the -cy-
ano-3-phenoxybenzyl subfamily of pyrethroids
and a close structural relative of cypermethrin (see
Fig. 2), cyﬂuthrin might be hypothesized to cause
the CS syndrome. The combination of beta-
cyﬂuthrin-induced effects (i.e. salivation, hy-
pothermia, repetitive pawing movements and
choreoathetosis) found in the acute and sub-
chronic neurotoxicity studies are generally consis-
tent with the CS syndrome of intoxication.
3.3.2.4. Lambda-cyhalothrin. In the acute neuro-
toxicity study with lambda-cyhalothrin (Barmmer,
1999), the FOB was performed approximately 7 h
following the administration of 2.5, 10 or 35
mg/kg in corn oil to Alderley Park rats. At the 35
mg/kg dose, this compound caused decreased ac-
tivity, ataxia, reduced stability, tiptoe gait, de-
creased landing foot splay and decreased tail ﬂick
response. Some signs were also evident at 10
mg/kg dose but not at the lowest dose level.
Cyhalothrin, another member of the -cyano-3-
phenoxybenzyl structural subfamily (see Fig. 2),
was not included among the compounds on which
the T/CS classiﬁcation syndrome is based. The
effects observed in the acute neurotoxicity study
with lambda-cyhalothrin are not speciﬁc to either
syndrome of intoxication. Thus, these results do
not support inclusion of this pyrethroid into ei-
ther category.
3.3.2.5. Cypermethrin. In the acute neurotoxicity
study with cypermethrin (Freeman, 1993a), the
FOB was performed at approximately 4 h follow-
ing the administration of the compound at 30, 100
or 200 mg/kg in corn oil to male and female
Sprague–Dawley rats. Animals that received
doses of 100 or 200 mg/kg exhibited salivation,
oral discharge, abdominogenital staining, ataxia,
staggered gait, decreased locomotor activity, and
mortality. No effects were evident at the lowest
dose of 30 mg/kg. For the subchronic study (Free-
man, 1993b), cypermethrin was administered
through the diet to male and female Sprague–
Dawley rats, at concentrations of 500, 1300 and
1700 ppm (34, 86 and 111 mg/kg per day, respec-
tively). At the 1700-ppm dietary level, cyperme-
thrin caused tremor, ataxia, splayed hindlimbs,
abnormal posture, staggered gait, and impaired
aerial righting. Splayed hindlimbs and staggered
gait were also evident at the 1300-ppm dietary
level, but no effects were seen at 500 ppm. In a
published study (McDaniel and Moser, 1993),
cypermethrin was administered by gavage in corn
oil to Long-Evans hooded rats at doses of 20, 60
and 120 mg/kg, and the animals were evaluated
using an FOB at 1.5 and 3 h following treatment.
Results of this study that are generally consistent
with those of the regulatory acute neurotoxicity
studies include salivation, urination, ataxia and
tremors. However, the absence of a staggering
gait and the presence of a ﬂattened body posture
with splayed limbs, increased landing footsplay
and choreoathetosis in the latter study are not
consistent with the ﬁndings of the regulatory neu-
rotoxicity study.
Both the 1R,trans,RS and 1R,cis,RS isomers
of cypermethrin were previously identiﬁed as pro-
ducing the CS syndrome of intoxication in rats
and mice (Verschoyle and Aldridge, 1980;
Lawrence and Casida, 1982). Among the signs of
intoxication found in the regulatory neurotoxicity
studies, the presence of splayed hindlimbs is con-
sistent with the CS syndrome. Otherwise, the signs
that are used to distinguish the CS syndrome of
intoxication were generally absent from both reg-
ulatory neurotoxicity studies. The signs of intoxi-
cation reported by McDaniel and Moser (1993)
are more consistent with the CS syndrome than
those of the regulatory studies. The basis for this
difference in outcome is not known. Whereas the
vehicle and source of test substance were the same
in both studies, there are also many differences
between the studies (e.g. animal strain, dose selec-
tion, observation time points and other differ-
ences in study design) that could have contributed
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3.3.2.6. Zeta-cypermethrin. For the acute neuro-
toxicity study of zeta-cypermethrin (Watt, 1998b)
the FOB was performed at the time of peak
effects, approximately 4–6 h following the admin-
istration of 10, 50 or 250 mg/kg of undiluted
compound to male and female Long-Evans rats.
There was one death at the highest dose. At the
two highest dose levels, zeta-cypermethrin caused
tremors, staggered gait, ataxia, loss of muscle
control, splayed hindlimbs, immobility, an im-
paired righting response and convulsions. No ef-
fects were evident at the lowest dose of 10 mg/kg.
For the subchronic study (Freeman, 1999), zeta-
cypermethrin was administered through the diet
to male and female Long-Evans rats, at concen-
trations of 75, 400 and 750 ppm (5, 29 and 51
mg/kg per day, respectively). At the 750-ppm
dietary level, zeta-cypermethrin caused decreased
activity, increased tail ﬂick latency, and increased
landing foot splay. Decreased activity was the
only evidence of toxicity at the next lower dose
and no effects were observed at the lowest dose in
both sexes.
Zeta-cypermethrin, the 1RS,cis,trans,S isomer
of cypermethrin, contains four of the eight iso-
mers present in fully racemic cypermethrin includ-
ing both of the isomers (e.g. the 1R,trans,S and
1R,cis,S isomers) expected to exhibit high mam-
malian toxicity (see Table 2). Because other iso-
meric mixtures of cypermethrin containing the
two most active isomers were identiﬁed as causing
the CS syndrome in rats and mice (Verschoyle
and Aldridge, 1980; Lawrence and Casida, 1982),
zeta-cypermethrin would be expected to produce
the CS syndrome under similar assay conditions.
Among the ﬁndings of the regulatory neurotoxic-
ity studies the presence of splayed hindlimbs and
convulsions are consistent with the CS-type syn-
drome but other ﬁndings are not speciﬁc to either
syndrome of intoxication.
3.3.2.7. Deltamethrin. In the acute neurotoxicity
study of deltamethrin (Nemec, 1998a), the FOB
was performed approximately 3 h following the
administration of 5, 15 or 50 mg/kg of
deltamethrin in corn oil to male and female
Sprague–Dawley rats. Animals treated with 50
mg/kg of deltamethrin exhibited salivation, a ﬂat-
tened posture with limbs extended, clonic and
tonic convulsions, tremor, biting or gnawing the
cage, eyelid ptosis, decreased reaction to removal
and handling, lacrimation, decreased arousal, al-
ternating limb movements with wave-like move-
ments of the abdomen (choreoathetosis),
hindlimbs splayed or dragging, decreased re-
sponse to stimuli, increased auditory startle re-
sponse, impaired aerial righting response, reduced
forelimb grip strength, impaired rotorod perfor-
mance, decreased fore- and hindlimb extensor
strength, decreased hindlimb foot splay, hypother-
mia, and mortality. At the next lower dose, the
only evidence of toxicity was salivation and im-
paired mobility. No effects were observed at the
lowest dose in both sexes. In the subchronic study
(Nemec, 1998b), deltamethrin was administered in
the diet to male and female Sprague–Dawley rats,
at concentrations of 50, 200 and 800 ppm (4, 15
and 56 mg/kg per day, respectively). At the 800
ppm dietary level, deltamethrin caused impaired
mobility and gait (rocking, lurching or swaying;
walking with hindlimbs splayed; walking on tip-
toes) and postural changes (body dragging with
hindlimbs splayed or dragging), hypersensitivity
to noise, impaired aerial righting reﬂex, reduced
grip strength, decreased hindlimb extensor
strength, piloerection, convulsions, popcorn
seizures, and mortality. There were no treatment-
related neurobehavioral ﬁndings at lower dietary
concentrations.
The signs of intoxication observed with
deltamethrin following either oral or intravenous
administration formed the basis of the original
description of the CS intoxication syndrome
(Barnes and Verschoyle, 1974). Several of the
signs observed in the regulatory neurotoxicity
studies (e.g. salivation, convulsions, choreoatheto-
sis, hypothermia and hindlimb splay) are also
consistent with the production of the CS syn-
drome by deltamethrin. Since the FOB does not
indicate whether the tremor caused by
deltamethrin was ﬁne or coarse, it is not known
whether this ﬁnding is consistent or inconsistent
with the CS classiﬁcation. Many other effects of
deltamethrin at the highest exposure levels (e.g.
decreased arousal, impaired righting, reduced grip
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at a lethal dose level, rather than evidence of a
speciﬁc syndrome of intoxication.
3.3.2.8. Permethrin. For the acute neurotoxicity
study (Freeman, 1993c), the FOB was performed
approximately 12 h following the administration
of 10, 150 or 300 mg/kg of permethrin in corn oil
to male and female Sprague–Dawley rats. At
doses of 150 and 300 mg/kg permethrin caused
salivation, tremor, splayed hindlimbs, abnormal
posture, staggered gait, decreased grip strength,
exaggerated reaction to sound, exaggerated
hindlimb ﬂexion, convulsions, and mortality. No
treatment-related effects were evident at the low-
e s td o s eo f1 0m g /kg. In a published behavioral
neurotoxicity study (McDaniel and Moser, 1993),
permethrin was administered by gavage in corn
oil to Long-Evans hooded rats, at doses of 25, 75
and 150 mg/kg, and the animals were evaluated
using an FOB at 2 and 4 h following treatment.
Results that are consistent with the acute regula-
tory study included tremor, chromodacryorrhea,
decreased grip strength and an exaggerated startle
response. However, the absence of salivation,
splayed hindlimbs and convulsions and the pres-
ence of aggressive sparring in the latter study were
inconsistent with the ﬁndings of the regulatory
acute neurotoxicity study. In the subchronic neu-
rotoxicity study (Freeman, 1993d), permethrin
was administered through the diet to male and
female Sprague–Dawley rats, at concentrations of
250, 1500 and 2500 ppm (18, 101 and 170 mg/kg
per day, respectively). At the 1500 and 2500 ppm
dietary levels permethrin produced tremor,
splayed hindlimbs, abnormal posture, a staggered
gait, and decreased grip strength. There were no
effects at the lowest dose of 250 ppm.
Various isomers and isomer mixtures of perme-
thrin were identiﬁed as causing the T syndrome of
intoxication in rats and mice (Verschoyle and
Aldridge, 1980; Lawrence and Casida, 1982).
However, the results of the regulatory neurotoxic-
ity studies suggest a mixed type of effect that is
not consistent with either classic syndrome of
intoxication. The tremor may be consistent with
the T-type syndrome, whereas salivation, splayed
hindlimbs, exaggerated hindlimb ﬂexion and con-
vulsions are signs that are more commonly associ-
ated with the CS syndrome. In contrast, the
ﬁndings in the published neurotoxicity study (Mc-
Daniel and Moser, 1993) are generally more con-
sistent with the production of the T syndrome.
The basis for this difference in outcome is not
known but, as with the different studies of cyper-
methrin (see Section 3.3.2.5) may lie in differences
in animal strain, dose, and observation criteria
between the studies.
3.3.2.9. Pyrethrum. For the acute neurotoxicity
study of pyrethrum (Hermansky and Hurley,
1993), the FOB was performed at approximately 3
h following the administration of 40, 125 or 400
mg/kg in males and 20, 63 or 200 mg/kg in
females. Doses were delivered in corn oil to
Sprague–Dawley rats. At the 200 and 400 mg/kg
dose levels pyrethrum produced salivation,
tremor, hyperthermia, urogenital wetness, an ex-
aggerated startle response, decreased grip strength
and hindlimb splay, and mortality. Tremor was
the only effect evident at the next lower dose level
and there were no effects evident in either sex at
the lowest dose.
Pyrethrum was identiﬁed as producing the T
syndrome of intoxication in rats (Verschoyle and
Barnes, 1972) and mice (Lawrence and Casida,
1982). However, the results of these neurotoxicity
studies suggest a mixed type of effect that is not
consistent with either classic syndrome of intoxi-
cation. Tremor and hyperthermia are consistent
with the T syndrome, whereas salivation and
hindlimb splay are more characteristic of the CS
syndrome.
3.3.3. Results of other behaioral neurotoxicity
studies
3.3.3.1. Effects on motor actiity. Crofton and
Reiter (1984, 1988a,b) compared the effects of
nine commercial or experimental pyrethroids (cis-
methrin, cyﬂuthrin, cypermethrin, deltamethrin,
fenvalerate, ﬂucythrinate, ﬂuvalinate, permethrin,
and RU 26607
4) on motor activity in rats. Com-
4 The diﬂuoro analog of deltamethrin: [S]--cyano-3-phe-
noxybenzyl-3-(2,2-diﬂuorovinyl)-2,2-dimethylcyclopropanecar-
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pounds were administered orally in corn oil and
motor activity was assessed in a ﬁgure-eight maze
at the time of peak effect (1.5–2 h after dosing as
deﬁned in these studies). All nine compounds
caused a dose-dependent decrease in motor activ-
ity, and no differences in this response were noted
between compounds identiﬁed by Verschoyle and
Aldridge (1980) as producing the T syndrome of
intoxication (cismethrin, permethrin) and those
producing the CS syndrome (cypermethrin,
deltamethrin, fenvalerate and RU 26607). The
potency of deltamethrin in these assays varied
more than 200-fold, depending on the vehicle and
route employed (Crofton et al., 1995). Other stud-
ies of the effects of deltamethrin on motor activity
employing different experimental protocols pro-
duced contradictory results. A single oral dose of
deltamethrin administered to mice caused a reduc-
tion in wheel-running behavior (Chanh et al.,
1984), a result consistent with the effects of
pyrethroids on motor activity summarized above
(Crofton and Reiter, 1984, 1988a,b). In contrast,
daily oral administration of deltamethrin to rats
for 15 days caused an increase in spontaneous
motor activity measured on the day following the
last dose (Husain et al., 1996).
3.3.3.2. Effects on acoustic startle response.
Crofton and Reiter (1984, 1988a,b) also assessed
the effects of nine pyrethroids (cismethrin,
cyﬂuthrin, cypermethrin, deltamethrin, fenvaler-
ate, ﬂucythrinate, ﬂuvalinate, permethrin, and
ethanomethrin) on the acoustic startle response of
rats. Compounds were administered orally in corn
oil and the latency to onset and peak amplitude of
startle responses to standard acoustical stimuli
were assessed 1.5–2 h after dosing. Compounds
identiﬁed by Verschoyle and Aldridge (1980) as
producing the T syndrome of intoxication (cis-
methrin, permethrin, and ethanomethrin) in-
creased the amplitude of the startle response
without affecting its latency, whereas compounds
classiﬁed as producing the CS syndrome of intox-
ication (cypermethrin, deltamethrin and fenvaler-
ate) produced varied effects. Cypermethrin and
deltamethrin decreased the amplitude and in-
creased the latency of the startle response,
whereas fenvalerate increased the amplitude and
did not affect latency and also, unlike any other
compound tested, increased sensitization to back-
ground acoustical stimuli. Among the three com-
pounds not formally classiﬁed according to the
T/CS taxonomy of intoxication syndromes,
cyﬂuthrin and ﬂucythrinate decreased the ampli-
tude and increased the latency of acoustic startle
responses in a manner similar to cypermethrin
and deltamethrin, whereas ﬂuvalinate had no ef-
fect on any measure of the acoustic startle re-
sponse. In another study (Hijzen and Slangen,
1988), cypermethrin, fenﬂuthrin, and permethrin
increased the amplitude of the acoustic startle
response in rats, whereas deltamethrin decreased
the amplitude of this response. The effects of
permethrin and deltamethrin in this study are
generally consistent with the ﬁndings of Crofton
and Reiter (1984, 1988a,b), but the increase in
startle amplitude caused by cypermethrin is an
unexpected and contradictory ﬁnding.
3.3.3.3. Effects on conditioned behaior. Intraperi-
toneal administration of allethrin, deltamethrin,
fenvalerate or permethrin to rats caused a dose-
dependent reduction in the frequency of a previ-
ously-learned behavior (i.e. bar-pressing
reinforced by food) (Bloom et al., 1983; Stein et
al., 1987). Oral administration of either cyperme-
thrin or permethrin to rats caused similar reduc-
tions in food-reinforced learned behavior (Peele
and Crofton, 1987). Daily oral administration of
deltamethrin to rats for 15 days also reduced
learning and memory measured in a Y-maze using
a negatively reinforced visual discrimination re-
sponse (Husain et al., 1996).
3.3.4. Summary
The regulatory neurotoxicity studies summa-
rized here provide a unique opportunity to com-
pare the actions of different pyrethroids
determined under standardized experimental con-
ditions. Each of these pyrethroids produced a
distinct combination of neurobehavioral effects at
the highest dose tested. Moreover, comparisons of
the ﬁndings for any given pyrethroid between
acute and subchronic studies and of the results for
two isomeric compositions of cypermethrin that
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tency and reproducibility of the signs of intoxica-
tion derived from the FOB. However, a detailed
assessment of how closely these pyrethroids com-
pare with each other or with either classical syn-
drome of intoxication (i.e. T or CS) is limited by
several factors, including: a lack of concurrence
between the signs reported in intravenous toxicity
studies (Verschoyle and Aldridge, 1980) with ob-
servations used to characterize the effects in the
regulatory studies by the oral route (e.g. whether
tremor was coarse or ﬁne and the nature of
postural changes or gait abnormalities); differ-
ences in dose selection; and the absence of data
for several registered pyrethroids.
Despite these limitations, it is possible to reach
some conclusions from these results. For example,
it appears that two of the pyrethroids examined in
these studies (deltamethrin and cyﬂuthrin) pro-
duced signs of intoxication that conform generally
to the CS syndrome, three compounds (perme-
thrin, S-bioallethrin, pyrethrum) produced a mix-
ture of signs associated with the T and CS
syndromes, and three (bifenthrin, cyhalothrin,
cypermethrin) produced signs of intoxication that
did not clearly correspond to either syndrome. It
is noteworthy that none of the compounds iden-
tiﬁed previously as producing the T syndrome
(permethrin, S-bioallethrin, pyrethrum) caused
signs of intoxication in regulatory neurotoxicol-
ogy studies that were exclusively correlated with
the T syndrome. These results show that the T/CS
classiﬁcation system of intoxication syndromes is
not adequate to describe the various com-
binations of effects seen with these compounds
following oral administration. Additional studies
with other pyrethroids, including the remaining
registered compounds for which comparable
data are not currently available, would serve to
clarify these relationships further. Finally, it is
also clear from these studies that the effects of
each of these pyrethroids is reversible following
acute exposure, and that these compounds cause
limited cumulative toxicity following sustained ex-
posure.
In contrast to the highly comparable experi-
mental design employed for regulatory neurotoxi-
city studies of different pyrethroids, reports of the
behavioral effects of pyrethroids in the published
literature describe studies that involved a variety
of routes and schedules of administration, test
methods, and assay endpoints. Whereas, these
studies identify additional endpoints for the be-
havioral effects of pyrethroids that are not explic-
itly included in the FOB employed in regulatory
studies, they are of limited value in delineating
similarities and differences in the behavioral ef-
fects of different pyrethroids.
3.4. Paresthesia
The experience of workers involved in the han-
dling of technical or formulated pyrethroids, ei-
ther during manufacture or use, provides insight
into the effects of pyrethroids on humans follow-
ing cutaneous exposure. A large body of occupa-
tional exposure data, encompassing published
clinical reports and unpublished reports obtained
from industrial sources, has been assembled in
two review articles (Vijverberg and van den
Bercken, 1990; Clark, 1995). The most frequently-
reported symptom in worker exposure studies was
paresthesia, which was characterized by numb-
ness, itching, burning, or tingling of the skin
following dermal exposure to a pyrethroid. These
sensations generally occurred in the absence of
erythema, edema, vesiculation, or other signs of
overt skin irritation and were usually limited to
the directly exposed areas of the skin. Pyrethroid-
induced paresthesia was transient and reversible
within hours after exposure, but in some instances
it lasted for up to 48 h.
In studies of workers who experienced cuta-
neous sensations following pyrethroid exposure,
no clinical signs of acute pyrethroid intoxication
were observed (Vijverberg and van den Bercken,
1990; Clark, 1995). In addition, no exposure-re-
lated differences were detected in hematology
parameters or in heart, lung, liver, kidney, or
nervous system function in these individuals.
Further, electrophysiological assessment of pe-
ripheral nerve function did not detect any abnor-
malities related to occupational exposure to
pyrethroids.
Reports of occupational exposure are sup-
ported and ampliﬁed by the results of studies with
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human volunteers, the effects of four pyrethroids
(cypermethrin, fenvalerate, ﬂucythrinate and per-
methrin) were evaluated by application to the
earlobe (Flannigan and Tucker, 1985). In this
study, permethrin caused the least pronounced
and ﬂucythrinate the most pronounced paresthe-
sia, whereas cypermethrin and fenvalerate were
intermediate and approximately equal in effect. In
each case, paresthesia developed within 30 min of
exposure, peaked by 8 h, and dissipated by 24–32
h after exposure.
In studies with guinea pigs, the onset of abnor-
mal sensation caused by six pyrethroids (cyperme-
thrin, deltamethrin, esfenvalerate, fenvalerate,
ﬂucythrinate and permethrin) was judged by an
increase in scratching, licking or biting behavior
at the site of dermal application (Cagen et al.,
1984). The onset of symptoms usually occurred
within 1 h after application. However, permethrin
elicited a qualitatively lower overall response than
the other ﬁve compounds tested, which were ap-
proximately equal in effect under these experi-
mental conditions. The latency and duration of
the behavioral response were affected by the for-
mulation employed for any single pyrethroid, but
the magnitude of the response was independent of
formulation.
The results of worker exposure data coupled
with the results of controlled experiments with
human volunteers and animals show that pares-
thesia appears to be an exclusively local effect. It
occurs only at the site of dermal exposure, is not
correlated with the appearance of a rash or other
signs of classical skin irritation, and is not associ-
ated with any signs of systemic intoxication.
Based on these observations and the proposed
origins of paresthesia in the sensory nervous sys-
tem (Rizzo et al., 1996), pyrethroid-induced pares-
thesia has been postulated to be a direct
excitatory effect of pyrethroids on small sensory
nerve ﬁbers in the skin rather than a response due
to classical skin irritation. We conclude from
these ﬁndings that paresthesia is a transient, local
effect of pyrethroids that is limited to the site of
exposure. Paresthesia is therefore distinct from
the signs of systemic intoxication and is therefore
not relevant to cumulative risk assessments based
on systemic intoxication.
4. Toxicokinetics and metabolism
4.1. Introduction
A large body of published literature describes
the toxicokinetics and metabolic fate of
pyrethroid insecticides in rodents and other ani-
mal species, and a more limited literature consid-
ers the fate of pyrethroids in humans. Whereas
much of the published literature on pyrethroid
metabolism appeared prior to 1985, additional
information on the fate of pyrethroids, particu-
larly those introduced since 1985, is available
from studies submitted to the EPA in support of
petitions for registration. The published literature
is summarized in several review articles
(Miyamoto, 1976; Ruzo and Casida, 1977; Hut-
son, 1979; Casida and Ruzo, 1980; Gray and
Soderlund, 1985; Bradbury and Coats, 1989;
Soderlund, 1992; Clark, 1995). A recent compre-
hensive summary of the metabolic fate of
pyrethroids (Roberts and Hutson, 1999) includes
extensive bibliographies of the published literature
describing the metabolic fate of all currently regis-
tered pyrethroids. The sections that follow brieﬂy
summarize the toxicokinetics and metabolic fate
of pyrethroids based on these reviews from the
perspective of the role of toxicokinetics and
metabolism in acute neurotoxicity.
4.2. Toxicokinetics
4.2.1. Absorption, distribution and excretion
documented in in io metabolism studies
Studies designed to elucidate the metabolic fate
of numerous radiolabeled pyrethroids in animals
(Roberts and Hutson, 1999) show that these com-
pounds are rapidly and extensively absorbed from
the gastrointestinal tract following oral adminis-
tration. The inﬂuence of administration vehicle on
acute oral toxicity (see Table 1) implies that the
vehicle affects the rate or extent of gastrointestinal
absorption, but there are no published studies
designed speciﬁcally to address this issue. In con-
trast, pyrethroids are poorly absorbed following
dermal exposure. A comparative study of the
gastrointestinal and dermal absorption of radiola-
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al., 1981) showed that at least 96% of an oral dose
was excreted after 6 days, whereas at least 78–
85% of the dermally-applied doses was recovered
unabsorbed from the surface of the skin and
3–17% of the doses was recovered in the excreta
after 6 days. The administration vehicle also
greatly inﬂuenced dermal absorption: absorption
of phenothrin isomers was 3-fold greater, based
on the proportion of phenothrin-derived radiocar-
bon recovered in the excreta, when presented in
an emulsiﬁable concentrate formulation than
when applied as a dust formulation. Pyrethroids
are anticipated to be efﬁciently absorbed from the
respiratory tract following inhalation (Clark,
1995). There are no published studies that directly
compare the efﬁciency of absorption by this route
with gastrointestinal absorption, but the similarity
of the LD50 values calculated for deltamethrin
following inhalation exposure to the values ob-
tained following oral administration (Kavlock et
al., 1979) implies that pyrethroids are readily ab-
sorbed from the respiratory tract.
The inﬂuence of pyrethroid toxicokinetics on
the availability of parent compound at sites in the
central nervous system, and therefore on the ex-
pression of acute toxicity, is further demonstrated
in studies correlating brain levels of cismethrin
and deltamethrin in rats and mice with the onset
of speciﬁc signs of acute intoxication. Administra-
tion of cismethrin to rats either orally or by
intravenous injection at different environmental
temperatures (White et al., 1976; Gray et al.,
1980) yielded acute LD50 values ranging from 4.5
to 1000 mg/kg. However, administration of
equitoxic doses, regardless of the route and
amount of compound administered, resulted in
the production of characteristic brain concentra-
tions that were associated with the onset of
tremors (3 nmol/g tissue) and with severe
tremors and death (12 nmol/g). Administration
of deltamethrin to rats identiﬁed threshold con-
centrations in the brain associated with salivation
(0.1–0.2 nmol/g), tremor (0.2–0.35 nmol/g), and
choreoathetosis (0.4–1 nmol/g) (Rickard and
Brodie, 1985). A similar brain threshold concen-
tration (1 nmol/g) for deltamethrin toxicity in
mice was obtained following administration of
equitoxic oral or intraperitoneal doses in various
vehicles (Ruzo et al., 1979). In contrast to the
strong correlation between brain levels and toxic
effects, blood levels of cismethrin and
deltamethrin in rats were poorly correlated with
signs of intoxication (White et al., 1976; Gray et
al., 1980; Rickard and Brodie, 1985).
Following a single oral dose, pyrethroids are
rapidly taken up by the blood and distributed
throughout the body. This behavior is exempliﬁed
by a balance and tissue retention study conducted
with cypermethrin (Crawford et al., 1981). In this
study, blood levels of both the cis and trans
isomers of cypermethrin peaked by the 1st day
after treatment and had declined to very low
levels by 8 days after treatment. A similar pattern
of distribution for both isomers was found with
other internal tissues examined (liver, kidney,
muscle, brain) and for the trans isomer in fat. The
only residue that was signiﬁcantly higher was that
of the cis isomer in fat, which was found to be
mostly unmetabolized cis-cypermethrin and was
eliminated from this tissue with an estimated half-
life of 12 days, a value similar to the half-lives
estimated for the much lower residues of this
compound in kidney and liver. This pattern of
internal distribution is similar to that found for
resmethrin (Miyamoto et al., 1971; Ueda et al.,
1975), permethrin (Gaughan et al., 1977), fen-
propathrin (Crawford and Hutson, 1977),
deltamethrin (Ruzo et al., 1978; Cole et al., 1982),
fenvalerate (Ohkawa et al., 1979; Lee et al., 1985),
and tralomethrin (Cole et al., 1982). The preferen-
tial distribution and greater persistence of
pyrethroids in fat was a common feature of these
studies, but the magnitude of these residues rela-
tive to administered dose varied with the
pyrethroid and isomer examined.
Following daily oral doses, pyrethroids achieve
approximately steady-state levels in internal tis-
sues within a few days. These levels persist
throughout the dosing period and then decline
when daily administration ceases. This behavior is
exempliﬁed in a study of the bioaccumulation and
persistence in rats of radiolabeled cypermethrin
administered at 2 mg/kg per day for 70 days
(Rhodes et al., 1984). Cypermethrin-derived ra-
diocarbon levels in the liver, kidney, and blood
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and then more slowly during the next 9 weeks, so
that levels at the end of 10 weeks were approxi-
mately twice those at the end of 1 week. Radio-
carbon levels in fat and skin also increased rapidly
during the 1st week; in skin, there was no further
accumulation during the following 9 weeks,
whereas in fat radiocarbon levels continued to
increase during the 2nd week and then were stable
for the remainder of the study. At the end of the
10-week dosing period, tissue levels were 0.5–
1.0 g cypermethrin equivalents/g tissue in blood,
liver, kidney, and skin and 5 g/g in fat. Upon
the cessation of dosing, radioactivity was elimi-
nated rapidly from blood, liver and kidney, reach-
ing background levels by 28 days after the
termination of dosing. Radioactivity levels de-
clined more slowly from fat and skin; analysis of
the cypermethrin isomer content of fat samples at
various times after the end of dosing showed that
the rate of elimination of the trans isomer from
fat was 5-fold faster than that of the cis isomer.
Following single oral doses, most pyrethroids
are rapidly excreted in the urine and feces. Typi-
cally, 90% of the administered dose is excreted
within a week after treatment (Roberts and Hut-
son, 1999). The rate of excretion and the distribu-
tion of pyrethroid derived radiolabel between
urine and feces varies with the compound and
isomer examined and the position of the radiola-
bel within the molecule. In particular, radiolabel
derived from the cyano group of -cyano-3-phe-
noxybenzyl esters is very slowly eliminated from
the body (Crawford et al., 1981) because this
moiety is cleaved during ester hydrolysis and con-
verted to thiocyanate, which has a pattern of
disposition and elimination very different from
pyrethroids and their component acid and alcohol
moieties (Ruzo et al., 1978; Ohkawa et al., 1979).
4.2.2. Toxicokinetic models for pyrethroids
Two published studies have modeled the toxi-
cokinetic behavior of permethrin (Anadon et al.,
1991) and deltamethrin (Anadon et al., 1996)
following single oral doses to rats. For both com-
pounds, the kinetics of absorption, distribution
and elimination were ﬁtted to a two-compartment
open model. Pyrethroid absorption was relatively
rapid, so that plasma levels were maximal within
4 h after dosing. Both pyrethroids were cleared
slowly from plasma with elimination half-lives of
12.4 (permethrin) and 38.5 h (deltamethrin). For
both compounds, maximum concentrations in
various elements of the central and peripheral
nervous system were higher than plasma concen-
trations and declined with half-lives similar to
those measured for plasma.
4.2.3. Toxicokinetics in humans
Few studies are available that describe the toxi-
cokinetic behavior of pyrethroids in humans.
Studies using an in vitro model of penetration
through human skin (Shehata-Karam et al., 1988)
showed that the penetration of fenvalerate was
much slower than that of carbofuran, parathion,
or lindane. Another study described the adminis-
tration of cypermethrin orally or dermally to hu-
man volunteers followed by quantitation of
metabolites excreted in the urine (Woollen et al.,
1992). This study documented the much greater
absorption of cypermethrin by the oral route (
36% of the administered dose) than the dermal
route (1.2% of the administered dose) based on
quantitation of the excreted metabolites in urine
samples. Additional studies of cypermethrin and
cyﬂuthrin in human volunteers exposed orally or
dermally (Eadsforth and Baldwin, 1983; Eads-
forth et al., 1988; Ku ¨hn et al., 1999) further
document the rapid elimination of cypermethrin
metabolites in the urine following exposure. In a
study of pest control operators receiving occupa-
tional exposure to cypermethrin or cyﬂuthrin, the
mean elimination half-lives for cyﬂuthrin and
cypermethrin metabolites in the urine were found
to be 5.52 and 8.09 h, respectively (Ku ¨hn et al.,
1999).
A case of intentional ingestion of an emul-
siﬁable concentrate formulation of permethrin
provided an opportunity to assess the clearance of
trans- and cis-permethrin from the blood during
the individual’s recovery from intoxication (Go-
toh et al., 1998). Serum concentrations of perme-
thrin peaked 3–4 h after ingestion and then
declined. Levels of the trans isomer were below
the limits of detectability within 25 h after expo-
sure, whereas cis-permethrin was still present at
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ferential persistence of the cis and trans isomers is
consistent with toxicokinetics and metabolic fate
of cis and trans permethrin in animal studies.
4.3. Metabolism
4.3.1. Pathways of pyrethroid metabolism
The metabolic fate of most pyrethroids in ani-
mals is described by the generalized pathway
shown in Fig. 5. The initial biotransformation of
the parent compound results from attack by either
esterases at the central ester bond or cytochrome
P450-dependent monooxygenases at one or more
sites in the acid or alcohol moieties. Although
most oxidative pathways yield hydroxyester
metabolites, oxidative ester cleavage may be a
minor pathway for some pyrethroids. The relative
importance of initial hydrolytic or oxidative at-
tack varies from compound to compound and
from isomer to isomer for each pyrethroid. Fol-
lowing ester cleavage, primary alcohol moieties
(e.g. 3-phenoxybenzyl alcohol) undergo further
oxidation via the aldehyde to the corresponding
carboxylic acids, whereas -cyano-substituted al-
cohols lose cyanide non-enzymatically to form the
corresponding aldehyde. A portion of these ester
cleavage products may be hydroxylated, and a
portion of the hydroxylated ester metabolites may
be hydrolyzed, thereby producing hydroxylated
ester cleavage products. Further metabolism of
these initial products of hydrolytic or oxidative
attack involves conjugation with amino acids,
sugars, sugar acids, or sulfate prior to excretion.
In vivo metabolism studies are supported by stud-
ies employing in vitro preparations from mam-
malian tissues, which identify tissues having high
levels of pyrethroid-metabolizing activity and the
enzyme activities catalyzing the principal bio-
transformation pathways for pyrethroids.
4.3.2. Pyrethroid metabolism in humans
Information on the metabolic fate of
pyrethroids in humans is limited to a small num-
ber of studies involving volunteers or persons
exposed to pyrethroids in the course of their
occupations. For workers exposed to allethrin
(Leng et al., 1999) and volunteers or workers
exposed to permethrin, cypermethrin, cyﬂuthrin,
or deltamethrin (Eadsforth and Baldwin, 1983;
Eadsforth et al., 1988; Woollen et al., 1992; Leng
et al., 1996; Llewellyn et al., 1996; Ku ¨hn et al.,
1999), the metabolites identiﬁed in urine samples
were consistent with the metabolic pathways for
these compounds identiﬁed in rodents.
4.3.3. Toxicological signiﬁcance of pyrethroid
metabolism
Two lines of evidence suggest that the ﬁrst
metabolic attack on a pyrethroid, whether hy-
drolytic or oxidative, generally achieves detoxica-
tion of the parent compound. First, the acute
toxicity of pyrethroids to mammals can be en-
hanced in several cases by compounds that inhibit
liver esterases and monooxygenases (Soderlund
and Casida, 1977; Casida et al., 1983; Gray and
Soderlund, 1985). Second, the metabolites derived
from the ester cleavage products of permethrin,
which include compounds that are also major
metabolites of cypermethrin, deltamethrin, fen-
propathrin, and fenvalerate, are generally of equal
or lower acute toxicity to mammals than the
parent pyrethroids (Gaughan et al., 1977). These
two considerations imply that metabolism effec-
tively limits the expression of the acute toxicity of
pyrethroids in animals.
There is little published evidence implicating
pyrethroid metabolites as causative agents for
chronic or long-term effects of pyrethroid admin-
Fig. 5. Generalized pathway for the metabolism of pyrethroids
in mammals by hydrolytic ([H]), oxidative ([O]) and conjuga-
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istration. A notable exception involves the 2R,S
isomer of fenvalerate, which lacks the appropriate
stereochemistry in the acid moiety to confer high
insecticidal activity or mammalian toxicity (see
Fig. 4). This fenvalerate isomer is implicated as
the causative agent of microgranulomatous le-
sions in various tissues, following a stereospeciﬁc
transesteriﬁcation reaction that results in the for-
mation of a cholesterol ester conjugate of the 2R
isomer of the fenvalerate acid moiety (Kaneko et
al., 1986; Okuno et al., 1986). A subsequent in
vitro study conﬁrmed the stereospeciﬁc transester-
iﬁcation reaction responsible for the formation of
the cholesterol ester of the 2R enantiomer of the
fenvalerate acid moiety and identiﬁed analogs of
fenvalerate that yielded cholesterol ester products
in vitro, but did not identify transesteriﬁcation
products arising from the pyrethroids phenothrin,
cyphenothrin, and fenpropathrin (Kaneko et al.,
1988).
4.4. Summary
The disposition of pyrethroids in animals is
governed by two properties shared by all insecti-
cides of this class: their high degree of lipophilic-
ity and their susceptibility to metabolic attack at
multiple sites. The lipophilicity of pyrethroids fa-
vors absorption in the gastrointestinal and res-
piratory tracts but limits absorption through the
skin and also confers preferential distribution into
lipid-rich internal tissues, including body fat and
elements of the central and peripheral nervous
system.
The time course of pyrethroid distribution is
well-correlated with the onset and duration of the
signs of intoxication that are observed in acute
neurotoxicity studies. In the case of permethrin,
the peak plasma concentration following oral ad-
ministration was achieved 4 h after dosing (Ana-
don et al., 1991), suggesting that concentrations in
plasma reach their peak in advance of the time to
peak effect (12 h) found in acute neurotoxicity
studies (see Section 3.3.2.8). In the case of
deltamethrin, the peak plasma concentration was
achieved 2 h after oral treatment (Anadon et al.,
1996) and the time to peak effect in acute neuro-
toxicity studies was 3 h after treatment (see
Section 3.3.2.7). Plasma levels of both permethrin
and deltamethrin declined to 10% of peak lev-
els by 48 h after treatment (Anadon et al., 1991,
1996). These ﬁndings are in good agreement with
the reversibility of acute intoxication by
pyrethroids following sublethal oral doses (see
Section 3.3).
The metabolic ability of pyrethroids, which re-
sults from attack by both esterases and cy-
tochrome P450-dependent monooxygenases,
insures that accumulation and persistence in lipid-
rich tissues is not excessive and that pyrethroids
are cleared from the body over a period of days to
weeks after the cessation of exposure. The signiﬁ-
cance of pyrethroid metabolism as a limiting fac-
tor in the expression of acute toxicity is evident in
the synergism of pyrethroid intoxication by com-
pounds that inhibit biotransformation enzymes.
The products of pyrethroid biotransformation
typically exhibit lower acute toxicity than the
parent pyrethroids, thereby implying that any
acute hazard associated with these compounds is
conferred by the toxicological properties of the
parent material. Finally, with the notable excep-
tion of one isomer of fenvalerate having low
insecticidal activity and mammalian toxicity, the
metabolites of pyrethroids are not implicated as
causative agents for chronic or long-term effects.
5. Physiological and neurochemical indices of
intoxication
Administration of pyrethroids at doses that
cause overt signs of acute intoxication produces a
variety of effects that are detected using physio-
logical and biochemical assays. The neurophysio-
logical, neurochemical, and cardiovascular effects
associated with acute pyrethroid intoxication are
summarized in the following sections.
5.1. Neurophysiology
Electroencephalographic studies of altered
brain function during pyrethroid intoxication are
limited to studies of two pyrethroids, deltamethrin
and cypermethrin. Studies of the action of
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thetized animals, showed altered patterns of corti-
cal and subcortical spiking, suppression of evoked
responses in the cortex, and an increase in caudate
neuronal activity (Ray and Cremer, 1979; Ray,
1980). These ﬁndings were interpreted as evidence
of a primary action of deltamethrin on the ex-
trapyramidal motor system of the rat. Daily in-
traperitoneal administration of cypermethrin to
rats, followed by electroencephalographic record-
ing for 30 min, identiﬁed episodes of paroxysmal
epileptic activity that appeared on the 1st or 2nd
day of cypermethrin administration that increased
progressively in number and duration throughout
the 10-day period (Conde ´s-Lara et al., 1999).
Electrophysiological assays of speciﬁc neuronal
pathways have also been employed to assess the
impact of systemically-administered pyrethroids
on the normal function of elements of the central
nervous system. Several studies have documented
the enhancement by a variety of pyrethroids of
synaptic inhibition in the hippocampal dentate
gyrus of the rat brain (Gilbert et al., 1989; Joy et
al., 1989, 1990; Joy and Albertson, 1991). In these
studies, pyrethroids classiﬁed as causing the T
syndrome of intoxication (e.g. cismethrin,
fenﬂuthrin) produced a transient enhancement of
inhibition, whereas compounds causing the CS
syndrome (e.g. deltamethrin, fenvalerate) pro-
duced a more persistent enhancement of inhibi-
tion and compounds classiﬁed as producing
elements of both the T and CS syndromes (e.g.
cyphenothrin, fenpropathrin) gave effects of inter-
mediate duration. The enhancement of inhibition
by pyrethroids in this system was interpreted to be
the result of excitatory presynaptic effects on in-
hibitory interneurons in the dentate gyrus. In
assays with spinal cord preparations, cismethrin
increased the excitability of both monosynaptic
and polysynaptic spinal reﬂexes in the rabbit
(Carlton, 1977) and enhanced dorsal root poten-
tials in the rat (Smith, 1980), whereas cis-perme-
thrin and deltamethrin both increased the
excitability of spinal neurons in both the rat and
the cat (Staatz-Benson and Hosko, 1986).
Electrophysiological assays have also revealed
effects of systemically-administered pyrethroids
on elements of the peripheral nervous system. In
the rabbit, cismethrin lowered the response
threshold of hair follicle receptors and produced
spontaneous activity in some sensory cells and
repetitive ﬁring in afferent sensory nerves follow-
ing electrical stimulation (Carlton, 1977). In the
cat, cis-permethrin but not deltamethrin enhanced
both spontaneous and evoked activity in the sci-
atic nerve (Staatz-Benson and Hosko, 1986). Both
cismethrin and deltamethrin increased the ex-
citability of rat tail nerve preparations (Parkin
and Le Quesne, 1982; Takahashi and Le Quesne,
1982). Pyrethroids classiﬁed as producing the T
syndrome of intoxication (e.g. cismethrin,
fenﬂuthrin) and those classiﬁed as producing ele-
ments of both the T and CS syndromes (cyphe-
nothrin, fenpropathrin) produced excitatory
effects on sensory and motor neurons in the rat
trigeminal reﬂex pathway, but ﬁve compounds
classiﬁed as producing the CS syndrome (ﬂuoro-
cyphenothrin, cyhalothrin, cyﬂuthrin,
deltamethrin and fenvalerate) did not cause repet-
itive discharges in this neuronal pathway at doses
that caused repetitive activity in skeletal muscle
(Forshaw and Ray, 1986; Wright et al., 1988).
5.2. Neurochemistry
Pyrethroid-dependent neurotransmitter release
from presynaptic nerve terminals in the brain was
ﬁrst documented in rats treated with deltamethrin
(Aldridge et al., 1978). Deltamethrin treatment
resulted in a signiﬁcant decrease in acetylcholine
levels in whole brain and, most signiﬁcantly, in
the cerebellum. In contrast, cismethrin produced
no signiﬁcant reduction in acetylcholine levels
(Aldridge et al., 1978). Other effects of
pyrethroids in the cerebellum include
deltamethrin- and cypermethrin-induced increases
in cyclic guanosine monophosphate levels
(Aldridge et al., 1978; Lock and Berry, 1981;
Brodie and Aldridge, 1982; Brodie and Opacka,
1987) and enhanced calcium-dependent neuro-
transmitter release by fenvalerate from rabbit stri-
atal slices but not from hippocampal slices (Eells
and Dubocovich, 1988). Pyrethroids also in-
creased the levels of some amino acid neurotrans-
mitters and metabolites of monoamine
neurotransmitters in the brain. At doses that pro-
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levels of aspartate in the brainstem and striatum,
the levels of glutamate in the brain stem, the levels
of serotonin metabolites in the hypothalamus,
brain stem, hippocampus, and brain stem, and the
levels of dopamine metabolites in the striatum
(Hudson et al., 1986). Similarly, allethrin, cyper-
methrin, fenvalerate, and permethrin increased
the levels of dopamine metabolites in the striatum
(Doherty et al., 1986b). Finally, recent studies
have documented marked alterations in the levels
of endogenous polyamines (spermine, spermidine,
putrescine), associated principally with Purkinje
neurons in the rat cerebellum, that are correlated
with changes in locomotive and aggressive behav-
iors following deltamethrin exposure (Husain et
al., 1992, 1994, 1996).
Selective effects of pyrethroids on the cerebel-
lum were also found in assays of brain glucose
levels during intoxication. Rat brain glucose levels
and brain blood ﬂow were elevated in all brain
areas except the cerebellum during writhing fol-
lowing a lethal dose of deltamethrin. In contrast,
glucose levels in the cerebellum were depleted,
indicating a high level of glucose utilization in this
region (Cremer et al., 1980, 1983). Cypermethrin
produced similar increases in cerebellar glucose
levels during writhing but resulted in elevated
cerebellar lactate concentrations during both
writhing and salivation (Lock and Berry, 1981).
Brain blood ﬂow was also increased signiﬁcantly
by cismethrin but, except for the cerebellum, this
increase was eliminated by blocking cortical va-
sodilation by atropine (Cremer et al., 1983). The
atropine-insensitive component of blood ﬂow ap-
peared to be due to increased cerebellar neuronal
activity caused by cismethrin (Cremer et al.,
1983).
5.3. Cardioascular effects
Lethal doses of deltamethrin produced an in-
creased arterial blood pressure level in writhing
adult rats (Ray and Cremer, 1979; Ray, 1982a;
Bradbury et al., 1983). In pithed rats, in which the
central nervous system no longer controls cardio-
vascular function, deltamethrin increased mean
and differential arterial blood pressure, pulse
pressure, and heart rate (Bradbury et al., 1983;
Forshaw and Bradbury, 1983). At doses that pro-
duced choreoathetosis in rats, deltamethrin in-
creased plasma noradrenaline and adrenaline to
levels as much as 100-fold higher than controls
(Cremer and Seville, 1982). Although this level of
plasma catecholamine could be responsible for
some cardiovascular effects, studies with isolated
hearts in vitro showed that deltamethrin increased
aortic output and mean systolic pressure follow-
ing pretreatment with reserpine, a catecholamine
reuptake blocker and anti-adrenergic tranquilizer
(Forshaw and Bradbury, 1983). This direct posi-
tive inotropic effect of deltamethrin on the heart
muscle has also been reported in anesthetized
dogs (Navarro-Delmasure, 1981) and in isolated
guinea pig atrial muscle (Berlin et al., 1984). In
contrast to deltamethrin, treatment with cis-
methrin resulted in no cardiovascular alterations
in intact or pithed animals and was without an
effect on isolated heart preparations (Ray, 1982a;
Cremer et al., 1983; Forshaw and Bradbury,
1983). Although cismethrin caused an approxi-
mately 10-fold increase in plasma catecholamines
(10% of the response level induced by
deltamethrin), this increase was correlated to
physiological responses that occurred due to in-
creased physical activity of the animal during the
tremor syndrome that was produced following
exposure (Cremer and Seville, 1982; Ray, 1982a).
Blood glucose and lactate levels in rats were
increased following treatment with deltamethrin
(Ray and Cremer, 1979; Cremer and Seville, 1982;
Ray, 1982a) and cypermethrin (Lock and Berry,
1981), particularly once choreoathetosis was es-
tablished. Mephenesin pretreatment, which elimi-
nated deltamethrin-induced choreoathetosis,
protected pithed rats from the increase in blood
glucose concentration, but similarly treated intact
rats, still elicited this increase (Bradbury et al.,
1983). Thus, only part of the increased blood
glucose level produced by deltamethrin can be
attributed to the physiological responses to
choreoathetosis and there is a portion of this
increase that is a result of an action of the
pyrethroids on supraspinal centers in the central
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5.4. Summary
The studies summarized in this section docu-
ment the neuroexcitatory effects of pyrethroids
that are associated with the onset of signs of acute
intoxication. These studies also provide evidence
that pyrethroid-dependent alterations in nerve
function encompass both central and peripheral
elements of the nervous system. Although
pyrethroid action does not appear to be restricted
to any particular region of the nervous system,
some regions appear to be more sensitive than
others. In particular, alterations in normal brain
function and neurochemistry that are associated
with intoxication are most commonly noted in the
cerebellum.
The responses of the central and peripheral
nervous system to pyrethroids, in themselves,
provide little insight into the mechanisms of
pyrethroid neurotoxicity. The observed neuroexci-
tatory effects are consistent with the modiﬁcation
of cellular excitability through an action on
voltage-dependent ion channels. Whereas such an
effect could also indirectly account for the en-
hanced neurotransmitter release and turnover as-
sociated with intoxication, the latter effects could
also arise from actions of pyrethroids on presy-
naptic elements that are speciﬁcally involved in
neurotransmitter release. The studies summarized
here do not, however, provide evidence for an
indirect neuroexcitatory effect of pyrethroids re-
sulting from an interference with inhibitory
neurotransmission.
6. Mechanisms of toxicity
6.1. Introduction
The action of pyrethroids on speciﬁc molecular
targets in mammals has been investigated using
both electrophysiological and biochemical tech-
niques. The strong evidence implicating the
voltage-sensitive sodium channel as the principal
site of insecticidal action of pyrethroids has led to
extensive studies of the action of pyrethroids on
mammalian sodium channels. However, actions
of pyrethroids on numerous other systems have
also been investigated, and some of the effects
identiﬁed in these studies may be relevant to the
neurotoxic actions of at least some pyrethroids.
The literature in these areas has been covered in
comprehensive review articles (Soderlund and
Bloomquist, 1989; Bloomquist, 1993a; Clark,
1995; Bloomquist, 1996). In the sections that fol-
low, we summarize information on the action of
pyrethroids on voltage-sensitive ion channels, lig-
and-gated ion channels, and other neuronal target
sites. We then propose criteria to assess the toxi-
cological signiﬁcance of putative target sites and
provide a critical evaluation of the toxicological
importance of the putative target sites discussed in
this section.
6.2. Actions of pyrethroids on oltage-sensitie
ion channels
6.2.1. Voltage-sensitie sodium channels
6.2.1.1. Function, structure and pharmacology.
Voltage-sensitive sodium channels mediate the
transient sodium permeability of the cell mem-
brane that is associated with the production of
action potentials in vertebrate and invertebrate
nerves and in vertebrate skeletal and cardiac mus-
cle. Voltage-sensitive sodium channel components
from electric eel electroplax, mammalian brain,
and mammalian skeletal muscle have been solubi-
lized and puriﬁed (Catterall, 1992; Kallen et al.,
1993; Catterall, 1995, 1996). A large glycosylated
 subunit (260 kDa) is a common feature of
puriﬁed channels; in addition, two smaller sub-
units (1 and 2; 33 and 36 kDa) are associ-
ated with sodium channels puriﬁed from the brain
and from skeletal muscle. Reconstitution experi-
ments with puriﬁed rat brain channel components
show that incorporation of the  and 1 subunits
into phospholipid membranes in the presence of
brain lipids or brain phosphatidylethanolamine is
sufﬁcient to produce channels that mimic the
functional properties of sodium channels in native
membranes.
Knowledge of the primary structure of mam-
malian sodium channels has been advanced
greatly over the past 15 years by the cloning and
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Fig. 6. Dendrogram depicting the evolutionary relationships among identiﬁed rat sodium channel  subunit isoforms calculated from
published amino acid sequences; the sensitivity of isoforms to TTX, where known, is indicated.
sodium channel subunits. Sodium channel  sub-
units in the nervous system and in skeletal and
cardiac muscle are encoded by a family of highly
homologous but distinct genes. The mouse and
human genomes contain at least 10 sodium chan-
nel  subunit genes that are conserved in structure
and genetic localization (Fig. 6) (Plummer and
Meisler, 1999). Sodium channel heterogeneity in
mammals is further increased by alternative
mRNA splicing of some isoforms (Sarao et al.,
1991; Schaller et al., 1992; Gustafson et al., 1993).
The structural diversity of sodium channel  sub-
unit isoforms and splice variants is the basis for
the well characterized functional and pharmaco-
logical diversity of sodium channels expressed in
different mammalian tissue types and at different
stages of development (Mandel, 1992). The het-
erogeneity of sodium channel  subunits in mam-
mals, and their distribution in both nerve and
muscle, contrasts with the situation in insects,
which appear to have only a single sodium chan-
nel  subunit gene that codes for physiologically
and pharmacologically important sodium chan-
nels and is expressed exclusively in the nervous
system (Hong and Ganetzky, 1994).
The central importance of sodium channels in
the function of excitable cells is evident in the
number and diversity of neurotoxicants and drugs
that act at the sodium channel, producing a vari-
ety of effects on channel function and neuronal
excitability. These agents have been used exten-
sively in both functional assays and radioligand
binding experiments to characterize the pharma-
cological properties of sodium channels. The ac-
tion of these agents has led to the
pharmacological identiﬁcation of numerous bind-
ing domains for natural and synthetic toxicants
on the sodium channel.
6.2.1.2. Electrophysiological studies of pyrethroid
action on sodium channels. The actions of
pyrethroid insecticides on sodium channels in in-
vertebrate and vertebrate nerve preparations have
been widely documented over the past four
decades and are extensively and critically summa-
rized in numerous reviews (Soderlund and
Bloomquist, 1989; Vijverberg and van den
Bercken, 1990; Narahashi, 1992; Bloomquist,
1993a; Clark, 1995; Soderlund, 1995; Bloomquist,
1996; Narahashi, 1996). Brieﬂy, intracellular mi-
croelectrode recordings of action potentials
demonstrate that pyrethroids produce a range of
effects on nerve excitability depending on the
structure of the pyrethroid employed (Lund and
Narahashi, 1983; Vijverberg et al., 1983). Natural
pyrethrins and a structurally heterogeneous group
of synthetic pyrethroids lacking the -cyano-3-
phenoxybenzyl alcohol moiety are characterized
by the induction of long trains of action poten-
tials (‘burst discharges’) following a single stimu-
lus with little or no effect on resting potential. In
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phenoxybenzyl alcohol moiety typically do not
produce repetitive ﬁring but instead block the
action potential upon repeated nerve stimulation
and depolarize the resting membrane potential.
Examination of a wide variety of pyrethroid
structures has also identiﬁed compounds with in-
termediate effects on neuronal excitability; these
compounds typically produce bursts of action po-
tentials of declining amplitude followed, after
repetitive stimulation, by nerve block.
Effects of pyrethroids on sodium channel func-
tion that underlie these effects on nerve excitabil-
ity have been elucidated using voltage and patch
clamp techniques. Under voltage clamp, neuroac-
tive pyrethroids prolong the deactivation of
sodium channels, which is evident as the produc-
tion of a slowly-decaying sodium tail current that
ﬂows following a depolarization–repolarization
cycle (Narahashi, 1992, 1996). In most prepara-
tions, pyrethroids also retard the closing (inactiva-
tion) of sodium channels during a depolarizing
pulse. Voltage-clamp experiments show that the
apparently divergent effects of pyrethroids on
nerve excitability observed in intracellular mi-
croelectrode recordings are the result of similar
effects on sodium channels (Lund and Narahashi,
1983; Vijverberg et al., 1983). Compounds that
produce burst discharges in intact nerves produce
tail currents that decay rapidly, whereas com-
pounds that produce use-dependent block of ac-
tion potentials produce extremely persistent tail
currents that exhibit little or no decay for several
seconds after repolarization and persist for several
minutes. The differences in tail current kinetics
between these groups of compounds are conceptu-
ally consistent with their different effects on
evoked action potentials: transient prolongation
of sodium channel inactivation and deactivation
results in a depolarizing after-potential and repeti-
tive ﬁring, whereas persistent prolongation of
sodium inactivation and deactivation produces
slow depolarization of the cell membrane and
concomitant block of the action potential. It is
also noteworthy that pyrethroids identiﬁed as
having intermediate behavior in intracellular
recordings produce tail currents under voltage
clamp conditions with intermediate decay kinetics.
Patch clamp studies of the action of pyrethroids
on single sodium channels are limited to a much
smaller group of compounds. Tetramethrin, a
compound known to produce burst discharges in
intact nerves and transient sodium current prolon-
gation in voltage clamp experiments, increased the
mean open time of individual sodium channels in
patch clamp experiments approximately 10-fold
(Yamamoto et al., 1983). In contrast deltamethrin
and fenvalerate, compounds known to produce
use-dependent block of intact nerves and persis-
tent sodium current prolongation in patch clamp
experiments, increased mean open times of indi-
vidual sodium channels in voltage clamp studies
up to 200-fold and produced channels that re-
mained open at the end of the depolarizing pulse
(Chinn and Narahashi, 1986; Holloway et al.,
1989). Recordings of single sodium channels re-
vealed that deltamethrin also delayed channel
opening in response to a voltage pulse (Chinn and
Narahashi, 1986). These ﬁndings have been inter-
preted as evidence that pyrethroids stabilize multi-
ple channel states, slowing the transitions between
them.
Voltage and patch clamp experiments have also
been employed to assess the combined effects of
two different pyrethroids on sodium channels. In
voltage clamp experiments, initial exposure of
dorsal root ganglion neurons to either fenvalerate
(Song et al., 1996) or deltamethrin (Tabarean and
Narahashi, 1998) produced characteristic modiﬁ-
cations of sodium currents, including the induc-
tion of slowly-decaying tail currents. Subsequent
application of tetramethrin to these preparations
antagonized the effects of fenvalerate or
deltamethrin, so that the persistent tail current
associated with these compounds disappeared and
was replaced by the rapidly-decaying tail current
typical of the action of tetramethrin in this exper-
imental system. Subsequent patch clamp studies
of the action of tetramethrin and deltamethrin at
single sodium channels (Motomura and Nara-
hashi, 2001) conﬁrmed the results of voltage
clamp studies by documenting the displacement of
deltamethrin by subsequently applied te-
tramethrin. Interestingly, this study found no evi-
dence of the coexistence of tetramethrin- and
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from a single membrane patch. The results of
these studies yield two important and provocative
conclusions. First, pyrethroids that produce quali-
tatively divergent kinetic modiﬁcations of sodium
channels exert their effects either at a shared
binding site or at sites that are allosterically cou-
pled, so that occupancy of one site precludes
occupancy of the second. Second, for the combi-
nations of pyrethroids that have been examined,
effects of two different pyrethroids on both
macroscopic sodium currents and individual
sodium channels are antagonistic rather than ad-
ditive or synergistic.
6.2.1.3. Biochemical studies of pyrethroid action on
sodium channels. Biochemical studies of the ac-
tions of pyrethroids on sodium channels have
provided important information on the effects of
these insecticides on channels in the mammalian
central nervous system. Two types of experiments
have been employed: studies of the effects of
pyrethroids and other sodium channel-directed
toxins on radiosodium uptake into synaptic vesi-
cles, and studies of the effects of pyrethroids on
the binding of radioligands that label the sodium
channel. Pyrethroids alone do not affect ra-
diosodium uptake into brain synaptosomes, but
they enhance sodium uptake that is stimulated by
the alkaloid neurotoxins veratridine or batra-
chotoxin (Ghiasuddin and Soderlund, 1985;
Soderlund et al., 1987; Bloomquist and Soder-
lund, 1988). Pyrethroids also enhance the binding
of [
3H]batrachotoxinin A-20--benzoate (BTX-B),
an analog of batrachotoxin, to brain sodium
channels (Brown et al., 1988; Lombet et al., 1988).
Pyrethroid-dependent enhancement of sodium up-
take into presynaptic and postsynaptic nerve ter-
minals is also indirectly evident in assays of the
sodium-dependent components of neurotransmit-
ter release (Brooks and Clark, 1987; Eells and
Dubocovich, 1988), depolarization of synapto-
somes (Eells et al., 1992, 1993), and
phosophoinositide turnover in brain synaptoneu-
rosomes (Gusovsky et al., 1989).
Structure–activity relationships for the action
of pyrethroid isomers on rat and mouse brain
sodium channels in sodium uptake and radioli-
gand binding assays are in general agreement with
structure–toxicity relationships. The enhancement
of both veratridine-dependent sodium uptake into
brain synaptosomes and BTX-B binding to brain
sodium channels is stereospeciﬁc for deltamethrin
and the neurotoxic isomers of cypermethrin and
fenvalerate (Ghiasuddin and Soderlund, 1985;
Brown et al., 1988; Rubin et al., 1993). However,
structural analogs of deltamethrin and cyperme-
thrin lacking the -cyano substituent were much
less effective in these assays.
The results of these studies implied the exis-
tence of a pyrethroid binding site on sodium
channels, designated Site 6 by Lombet et al.
(1988), that is distinct from the sites labeled by
other radioligands and allosterically coupled to
the veratridine/batrachotoxin site. Initial attempts
to label this site with a pyrethroid radioligand
were unsuccessful (Soderlund et al., 1983; Lombet
et al., 1988) due to the extreme lipophilicity and
modest potency of the available pyrethroid radi-
oligands. More recent studies using a more potent
experimental pyrethroid as a radioligand have
demonstrated high-afﬁnity saturable binding to
brain sodium channels that exhibits the allosteric
coupling to other binding domains predicted by
previous studies (Trainer et al., 1997). However,
the utility of this ligand for the detailed character-
ization of pyrethroid binding is still limited by its
extreme lipophilicity, which produces high levels
of unsaturable, non-speciﬁc binding to cell mem-
branes and limits the sensitivity of the assay.
It is not clear from the available data whether a
single binding site on any given sodium channel
mediates the action of pyrethroids on that chan-
nel. Molecular genetic studies of pyrethroid resis-
tance in insects (see Section 2.2),
electrophysiological studies with dorsal root gan-
glion neurons, and biochemical studies using
mammalian brain sodium channels are consistent
with the existence of a single binding site per
channel protein associated with insecticidal activ-
ity and mammalian toxicity. However, studies of
the interactions of the isomers of tetramethrin
with sodium channels in squid giant axon prepa-
rations suggested the existence of multiple binding
sites with speciﬁcity for different isomers includ-
ing the 1S isomers that lack insecticidal activity
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of the effects of deltamethrin on the binding of
BTX-B to mouse brain sodium channels docu-
ment the allosteric antagonism of the effects of
deltamethrin by its -R epimer, which lacks
demonstrable mammalian toxicity (Rubin et al.,
1993). Whereas these studies imply the existence
of one or more additional sites on sodium chan-
nels that are capable of binding inactive isomers,
the toxicological signiﬁcance of such sites is not
established.
6.2.1.4. Differential pyrethroid sensitiity of sodium
channel isoforms. Most of what is known about
the actions of pyrethroids on mammalian sodium
channels has been learned using neuronal tissue
preparations, which are now known to express
multiple sodium channel  subunit isoforms. As a
result, the action of pyrethroids has not been
correlated with the expression of identiﬁed
sodium channel isoforms in these tissues. How-
ever, a limited number of physiological studies
suggest that sodium channel isoforms expressed in
various mammalian tissues exhibit differential
sensitivity to pyrethroids. Deltamethrin, but not
cismethrin or permethrin, has a direct positive
inotropic effect on the mammalian heart in addi-
tion to an indirect effect mediated by the stimula-
tion of catecholamine release (Forshaw and
Bradbury, 1983; Berlin et al., 1984; Daly et al.,
1987). Five -cyano pyrethroids (ﬂuorocyphe-
nothrin, cyhalothrin, cyﬂuthrin, deltamethrin, fen-
valerate) that produce the CS syndrome of
poisoning in the rat (Verschoyle and Aldridge,
1980) also cause repetitive action potentials in
directly-stimulated mammalian skeletal muscle
but do not cause repetitive discharges evoked by
sensory stimulation in the trigeminal reﬂex path-
way (Forshaw and Ray, 1986; Forshaw et al.,
1987; Wright et al., 1988). In contrast, three com-
pounds (cismethrin, fenﬂuthrin, NRDC 108) that
produce the T syndrome are inactive on skeletal
muscle but are active on sensory and motor neu-
ronal elements of the rat trigeminal reﬂex path-
way (Forshaw and Ray, 1986; Wright et al.,
1988). Two pyrethroids classiﬁed as intermediate
with respect to signs of intoxication (cyphe-
nothrin, fenpropathrin) are active on both nerve
and muscle in these assays (Wright et al., 1988).
These ﬁndings imply that pyrethroids affect multi-
ple sodium channel isoforms, including those not
expressed in the mammalian central nervous sys-
tem, and that these isoforms may vary in their
relative sensitivity to different pyrethroids.
The clearest evidence of differential sensitivity
to pyrethroids between sodium channel isoforms
is found in the responses of the tetrodotoxin
(TTX)-sensitive and TTX-resistant sodium chan-
nel populations in dorsal root ganglion cells to
pyrethroids. The TTX-resistant current in these
cells is much more sensitive than the TTX-sensi-
tive current to allethrin (Ginsburg and Narahashi,
1993), tetramethrin (Tatebayashi and Narahashi,
1994; Song and Narahashi, 1996) and
deltamethrin (Tabarean and Narahashi, 1998).
It is now possible to examine the functional and
pharmacological properties of individual cloned
sodium channel isoforms by expressing them in
unfertilized oocytes of the frog Xenopus laeis.
This model expression system synthesizes sodium
channel proteins from cloned cDNA injected into
the nucleus or synthetic messenger RNA injected
into the cytoplasm and inserts functional channels
into the cell membrane (Lester, 1988). Because
oocytes do not normally express endogenous
sodium channels, the properties of the expressed
channels can be investigated using electrophysio-
logical techniques (typically voltage or patch
clamp) without interference from endogenous
sodium currents (Stu ¨hmer, 1988).
Initial experiments using cloned sodium chan-
nel isoforms in the Xenopus oocyte expression
system examined the sensitivity of the rat brain
IIa sodium channel isoform (Auld et al., 1988),
which is abundantly expressed in the adult brain.
Expression of the rat brain IIa sodium channel 
subunit, either alone or in combination with the
rat 1 subunit, produced functional sodium chan-
nels in oocytes that were sensitive to modiﬁcation
by [1R,cis,S]-cypermethrin (Smith and Soder-
lund, 1998). These studies demonstrated that the
pyrethroid-binding site was intrinsic to the  sub-
unit. However, coexpression with the 1 subunit
increased the apparent afﬁnity of rat brain IIa
channels to pyrethroids more than 20-fold, thus
implying an allosteric effect of coassembly with
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Even in the presence of the 1 subunit, rat brain
IIa channels exhibited only modest sensitivity to
cypermethrin and deltamethrin. The potency of
cypermethrin and deltamethrin in these assays
was similar to the potency of RU39568, a struc-
turally-related -cyano pyrethroid, as a displacer
of the speciﬁc binding of a tritiated pyrethroid
radioligand to rat brain IIa sodium channels ex-
pressed in Chinese hamster ovary cells (Trainer et
al., 1997).
The effects of deltamethrin and related com-
pounds on rat brain IIa sodium channels exhib-
ited the stereospeciﬁcity predicted by
structure–toxicity relationships. Only
deltamethrin itself and its 1R,trans,S isomer,
which is neurotoxic to rats (Verschoyle and
Aldridge, 1980), were effective in modifying cur-
rents carried by rat brain IIa sodium channels,
whereas other isomers having the 1S or R
conﬁgurations, which have very low acute toxic-
ities, were inactive at the highest concentrations
attainable in this assay system (Smith and Soder-
lund, 1996).
Rat brain IIa channels expressed in oocytes
were completely insensitive to several pyrethroids
that produce the T syndrome (cismethrin,
fenﬂuthrin, tetramethrin) at the maximum nomi-
nal concentrations of pyrethroid that were attain-
able in this assay system (250 M) (Smith and
Soderlund, 1998). The complete insensitivity of
rat brain IIa channels to these compounds is
surprising in view of the well-established neuro-
toxic effects produced by these pyrethroids upon
direct injection into the brain (Gray and Soder-
lund, 1985). It is therefore likely that the central
neurotoxic effects of these pyrethroids, as well as
other compounds that produce the T syndrome,
are mediated by actions on one or more molecular
targets that are expressed in the central nervous
system other than the brain IIa sodium channel
isoform.
Preliminary experiments with rat skeletal mus-
cle (rSkM1) isoform suggest that this channel, like
the rat brain IIa channel isoform is also insensi-
tive to several non-cyano compounds and mod-
estly sensitive to [1R,cis,S]-cypermethrin and
deltamethrin (T.J. Smith and D.M. Soderlund,
unpublished results). This result is consistent with
the selective effects of -cyano compounds on
muscle action potentials observed in electrophysi-
ological assays (Forshaw and Ray, 1986; Forshaw
et al., 1987; Wright et al., 1988).
The actions of pyrethroids on the rat brain IIa
channel isoform were compared to those on the
rat SNS/PN3 sodium channel isoform, which is
preferentially expressed in the peripheral nervous
system and is distinguished by its high level of
resistance to TTX (Akopian et al., 1996;
Sangameswaran et al., 1996). In contrast to rat
brain IIa sodium channels, rat SNS/PN3 sodium
channels were highly sensitive to pyrethroids rep-
resenting both the T (cismethrin) and CS (cyper-
methrin) syndromes of intoxication (Smith and
Soderlund, 2001). The threshold cypermethrin
concentration for the modiﬁcation of SNS/PN3
channels was approximately 60-fold lower than
the threshold concentration for cypermethrin-de-
pendent modiﬁcation of rat brain IIa channels.
The biophysical properties, TTX resistance, and
pyrethroid sensitivity of the SNS/PN3 sodium
channel isoform expressed in oocytes suggest that
this isoform carries the TTX-resistant, pyrethroid-
sensitive sodium current found in dorsal root
ganglion neurons (Ginsburg and Narahashi, 1993;
Tatebayashi and Narahashi, 1994; Tabarean and
Narahashi, 1998).
6.2.2. Voltage-sensitie calcium channels
6.2.2.1. Function, structure, classiﬁcation and phar-
macology. Voltage-sensitive calcium channels are
ubiquitous in excitable membranes and modulate
a wide range of cellular events including the re-
lease of neurotransmitters and other secretions,
metabolic adjustments, cell proliferation, contrac-
tion, and control of gene expression. Voltage-sen-
sitive calcium channels are heterooligomeric
complexes comprised of several structurally dis-
similar subunits. Puriﬁcation of calcium channels
from vertebrate skeletal muscle has identiﬁed ﬁve
subunits (1, 2, ,  and ) with the large 1
subunit forming the ion-conducting pore of the
channel. Molecular cloning studies have shown
that calcium channel 1 subunits are members of a
multigene family that is evolutionarily related to
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There also are multiple isoforms of the  subunit
that differentially alter the biophysical properties
of calcium channels when co-expressed with a 1
subunit. The structural basis of calcium channel
diversity is still not completely understood, and
the relationship between calcium currents
recorded from native channels and currents
recorded from expressed channel subunit genes in
various combinations is not well established (Con-
ley and Brammar, 1999).
Several classes of calcium channels have been
identiﬁed based on their biophysical, electrophysi-
ological and pharmacological properties. An im-
portant biophysical distinction is that certain
channels are activated by only small depolariza-
tions (i.e. low-voltage activated), whereas others
are activated only in the presence of larger depo-
larizations (high-voltage activated). The high
voltage-activated channels are further subdivided
on the basis of tissue distribution and biophysical
and pharmacological properties into ﬁve classes
(L-, N-, Q-, P-, and R-types) whereas the low-
voltage activated channels are represented by only
one biophysical and pharmacological class (T-
type). Comparison of the deduced amino acid
sequences of numerous cloned 1 subunits has
resulted in a molecular classiﬁcation that divides
these subunits into 10 structural subgroups. Cor-
relation of structural subgroups with functional
channel types reveals that L- and T-type channels
exhibit the greatest molecular diversity, whereas
N-, P- and Q-type channels appear more homoge-
neous at the level of primary structure (Conley
and Brammar, 1999).
6.2.2.2. Electrophysiological studies of pyrethroid
action on calcium channels. Patch clamp tech-
niques detect distinct L- and T-type calcium cur-
rents in mouse neuroblastoma (N1E-115) cells. In
these cells, the non-cyano pyrethroid tetramethrin
blocked 75% of the T-type calcium current but
only 30% of the L-type current (Yoshii et al.,
1985). In contrast, the -cyano pyrethroids
deltamethrin and fenvalerate had no effect on
either calcium current. Similar results were ob-
tained in assays of the T- and L-type calcium
currents in single isolated sino-atrial node cells of
rabbit heart. In this study, tetramethrin com-
pletely blockled only the T-type calcium current
and resulted in a signiﬁcant slowing of the dias-
tolic depolarization in the latter two-thirds of the
pacemaker’s action potential in heart muscle
(Hagiwara et al., 1988). Tetramethrin also abol-
ished the T-type calcium currents in intestinal
smooth muscle cells from guinea pig in a dose
dependent manner but had no effect on L-type
currents (Yabu et al., 1989). Despite the lack of
effect of deltamethrin and fenvalerate on T- and
L-type currents in neuroblastoma cells, these com-
pounds have been reported to block calcium cur-
rents in guinea pig olfactory cortex slices
(Narahashi, 1987).
Two calcium currents (putatively associated
with L- and T-type calcium channels, respectively)
recorded from house ﬂy thoracic neurons exhibit
a differential response to deltamethrin (Duce et
al., 1999). Deltamethrin treatment resulted in a
signiﬁcant hyperpolarizing shift in the voltage de-
pendence of activation of the T-type current but
had no effect on the L-type current. This hyper-
polarizing shift was similar to the effect caused by
deltamethrin on the TTX-sensitive sodium current
recorded from the same preparation. Addition-
ally, deltamethrin increased the amplitude or fre-
quency of the spontaneous oscillations of internal
Ca
2+ and enhanced the amplitude of depolariza-
tion-induced increases in Ca
2+. These actions
were not altered by the presence or absence of
TTX but were blocked by verapamil, a pheny-
lalkylamine calcium channel antagonist.
6.2.2.3. Effects of pyrethroids on neurotransmitter
release in itro. The release of neurotransmitters is
a highly organized event dependent on external
calcium inﬂux via voltage-sensitive calcium chan-
nels associated with the plasma membrane of the
presynaptic nerve terminals (Llinas, 1982). N-type
calcium channels appear to play a dominant role
in depolarization-dependent release of neurotrans-
mitter, but P-/Q- and T-type calcium channels are
now known to be involved in neurotransmitter
release and also function in excitation-secretion
coupling and spontaneous ﬁring activity, respec-
tively (Conley and Brammar, 1999).
The ﬁrst in vitro ﬁndings that established the
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release of neurotransmitters were obtained using
isolated presynaptic nerve terminals (synapto-
somes) from guinea pig cortex (Nicholson et al.,
1987). Both deltamethrin and permethrin in-
creased spontaneous release but permethrin was
much less potent than deltamethrin. The sponta-
neous release of neurotransmitter was only par-
tially blocked by tetrodotoxin and was partially
dependent upon external calcium. A series of 25
pyrethroids also increased the spontaneous release
of neurotransmitters from rat brain synaptosomes
(Doherty et al., 1986a, 1987). Release promoted
by pyrethroids was only partially abolished by
tetrodotoxin or by substituting choline for
sodium, indicating an action at a site other than
the sodium channel. Fenvalerate, cypermethrin,
and deltamethrin also increased the spontaneous,
calcium-dependent release of dopamine and
acetylcholine from rabbit striatal brain slices
(Eells and Dubocovich, 1988). This spontaneous
release was concentration-dependent and was spe-
ciﬁc for the neurotoxic isomers of these
pyrethroids. Fenvalerate, however, had no effect
on the spontaneous release of neurotransmitters
from hippocampal brain slices, indicative of a
regional sensitivity difference to pyrethroids.
A more sensitive and marked enhancement of
pyrethroid-induced neurotransmitter release is ev-
ident following nerve terminal depolarization.
Treatment with deltamethrin, cypermethrin and
fenvalerate greatly enhanced a calcium-dependent
neurotransmitter release following the depolariza-
tion of rat brain synaptosomes by potassium
(Brooks and Clark, 1987). The deltamethrin-in-
duced release was highly correlated with calcium
uptake and only partially blocked by TTX (Clark
and Brooks, 1989), but release was completely
blocked by D595, a potent phenethylamine cal-
cium channel blocker (Brooks and Clark, 1987).
6.2.2.4. Biochemical studies of pyrethroid action on
calcium channels. Several pyrethroids have been
reported to inhibit the binding of a tritiated L-
type calcium channel blocker, [
3H]nimodipine, to
rat brain synaptosomes (Ramadan et al., 1988a).
However, the afﬁnity for pyrethroids in this assay
was low so that the concentration required for
inhibition exceeded that necessary to modify
voltage-sensitive sodium channels. In another
study, deltamethrin displaced
3H-verapamil (a
phenethylamine calcium channel blocker of L-
and T-type calcium channels) binding to rat brain
synaptic membranes (Kadous et al., 1994).
6.2.2.5. The Paramecium model: a study of
pyrethroid action in the absence of oltage-sensitie
sodium channels. Deltamethrin and resmethrin are
highly toxic to Paramecium tetraurelia, an organ-
ism that does not possess voltage-sensitive sodium
channels (Clark et al., 1995). In behavioral
bioassays, deltamethrin-treated P. tetraurelia ex-
hibited an increase in backward swimming (Clark
et al., 1995), a well-characterized avoidance re-
sponse controlled by calcium inﬂux via T-type
calcium channels associated with the ciliary mem-
brane (Ehrlich et al., 1984, 1988). The enantiomer
of deltamethrin, which has very low insecticidal
activity and mammalian toxicity, had no signiﬁ-
cant effect on either mortality or avoidance be-
havior. Pawn mutants, which lack a functional
calcium channel, were unaffected by deltamethrin.
Intracellular electrophysiological recordings of
whole P. tetraurelia showed that 10
−9 M
deltamethrin resulted in membrane destabiliza-
tion, increased spontaneous action potentials,
repetitive discharges, and membrane depolariza-
tion. These and other recent ﬁndings establish
that deltamethrin acts as a T-type calcium channel
agonist in P. tetraurelia (Symington et al., 1999).
6.2.3. Voltage-sensitie chloride channels
6.2.3.1. Function, structure and pharmacology of
oltage-sensitie chloride channels. Voltage-sensi-
tive chloride channels are a structurally diverse
and widely-distributed group of cell membrane
proteins (Jentsch, 1994; Gelband et al., 1996).
Molecular cloning has revealed two structural
classes of voltage-sensitive chloride channels that
are distinct from each other and structurally unre-
lated to the voltage sensitive cation (e.g. sodium
and calcium) channel family (Jentsch, 1996). The
CLC class of chloride channels, encoded by a
multi-gene family, are involved in the stabilization
of membrane resting potential, transepithelial
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all cell types (Jentsch, 1996). A second structural
class of voltage-dependent chloride channel
proteins is exempliﬁed by the cystic ﬁbrosis
transmembrane conductance regulator (CFTR), a
cell membrane protein that regulates chloride con-
ductance in epithelial cells that was ﬁrst identiﬁed
as the molecular locus of genetic defects that
cause cystic ﬁbrosis (Gelband et al., 1996; Jentsch,
1996).
The pharmacology of voltage-dependent chlo-
ride channels is poorly characterized due to the
lack of high-afﬁnity ligands speciﬁc for these
proteins (Gelband et al., 1996). Many compounds
that affect or bind to voltage-dependent chloride
channels, such as the convulsant t-butylbicy-
clophosphorotrithioate (TBPS), certain cyclodiene
insecticides, avermectins, and barbiturates, also
act at the GABA receptor–chloride ionophore
complex (Schwartz et al., 1984; Abalis et al., 1985;
Payne and Soderlund, 1991; Bloomquist, 1993b).
The existence of pharmacological crosstalk be-
tween different chloride channel types complicates
pharmacological discrimination between GABA-
gated and voltage-sensitive chloride channels.
6.2.3.2. Actions of pyrethroids: electrophysiological
studies in itro. Studies of the action of cismethrin
and deltamethrin on skeletal muscle showed that
deltamethrin but not cismethrin increased muscle
membrane resistance, which was suggested to re-
sult from a block of the chloride permeability of
the muscle membrane (Forshaw et al., 1987). A
subsequent study (Forshaw and Ray, 1990) conﬁ-
rmed the effect of deltamethrin but not cismethrin
on the input resistance of rat diaphragm skeletal
muscle ﬁbers and showed that a reduction in
extracellular chloride ion concentration prevented
the effects of deltamethrin. This study also docu-
mented similar effects of deltamethrin on the in-
put resistance of rat vagus nerve preparations that
were prevented by low extracellular chloride or
treatment of the preparation with ivermectin,
which activates neuronal voltage-dependent chlo-
ride channels (Abalis et al., 1986a). Patch-clamp
studies of single neuronal voltage-dependent chlo-
ride channels in excised membrane patches from
N1E-115 neuroblastoma documented the block-
ade of single channel conductance by
deltamethrin and cypermethrin but not cismethrin
(Forshaw et al., 1993; Ray et al., 1997).
6.2.3.3. Action of pyrethroids: pharmacological
studies in io. Studies in vivo of the interactions
between pyrethroids and agents known to act at
voltage-sensitive chloride channels provide further
insight into the involvement of this target in
pyrethroid intoxication. These experiments in-
volved co-administration of deltamethrin with
ivermectin (which is known to activate voltage-
sensitive chloride channels and have limited access
to the central nervous system), pentobarbital (a
barbiturate that selectively activates voltage-sensi-
tive chloride channels), or phenobarbital (which
exhibits sedative effects typical of barbiturates
without activating voltage-sensitive chloride chan-
nels) (Ray et al., 1999; Forshaw et al., 2000).
Intraperitoneal pretreatment of rats with iver-
mectin reduced the degree of salivation caused by
subsequent intravenous treatment with
deltamethrin and also reduced the incidence of
deltamethrin mortality and the motor signs of
deltamethrin intoxication at this dose, but iver-
mectin only affected salivation at a lower dose of
deltamethrin (Ray et al., 1999; Forshaw et al.,
2000). Ivermectin also reduced the severity of the
direct effects of deltamethrin on skeletal muscle
excitability in urethane-anesthetized rats (Ray et
al., 1999; Forshaw et al., 2000).
In parallel experiments, pentobarbital signiﬁ-
cantly antagonized the motor signs of intoxication
and reduced the degree of mortality in
deltamethrin-treated rats but was less effective
than ivermectin in reducing salivation (Ray et al.,
1999; Forshaw et al., 2000). In contrast, an equi-
sedative dose of phenobarbital (which lacks the
selectivity of pentobarbital for voltage-sensitive
chloride channels) reduced the number of deaths
in deltamethrin-treated rats but did not signiﬁ-
cantly affect salivation or the motor signs of
intoxication (Ray et al., 1999; Forshaw et al.,
2000). These studies were also extended to exam-
ine the effects of barbiturates on intoxication by
cismethrin, a pyrethroid without demonstrable ef-
fects on voltage-sensitive chloride channels in
vitro (see Section 6.2.3.2). Pentobarbital did not
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deaths in rats treated intravenously with cis-
methrin, but phenobarbital produced a signiﬁcant
reduction in lethality under these conditions (Ray
et al., 1999). These authors concluded that the
effects of ivermectin and pentobarbital on the
signs of deltamethrin intoxication reﬂected a spe-
ciﬁc antagonism of the action of deltamethrin on
voltage-sensitive chloride channels, whereas the
effects of pentobarbital and phenobarbital on the
lethality of both deltamethrin and cismethrin were
ascribed to central effects on neuronal excitability
that were not speciﬁcally attributable to an action
on chloride channels (Ray et al., 1999).
6.3. Actions of pyrethroids on ligand-gated ion
channels
6.3.1. GABA receptors
6.3.1.1. Function, structure, and pharmacology of
GABA receptors. The GABA (-aminobutyric
acid) receptor–chloride ionophore complex is an
important mediator of inhibitory neurotransmis-
sion in the mammalian nervous system (Macdon-
ald and Olsen, 1994). Release of GABA by
presynaptic nerve terminals activates a chloride
channel on the postsynaptic membrane, leading to
hyperpolarization of the postsynaptic nerve termi-
nal and thus requiring an increase in the amount
of excitatory input into that terminal in order to
excite the postsynaptic neuron. GABA receptors
are pentameric complexes composed of members
of a large group of structurally related subunit
proteins that comprise several structural classes
(designated , , , , ,a n d) with as many as
six isoforms in each class (Barnard et al., 1998).
Many GABA receptors in the vertebrate CNS are
formed from two  subunits, two  subunits, and
one  subunit, but the existence of multiple iso-
forms of these subunits, plus the incorporation of
subunits from other classes in some receptor sub-
types, results in a high level of molecular diversity
among GABA receptors.
GABA receptors are important target sites for
the action of several classes of therapeutic drugs
and toxicants (Johnston, 1996). Ethanol, barbitu-
rates, and benzodiazepine anxiolytics allosterically
modify the action of GABA. Blockers of the
chloride channel, which include naturally occur-
ring compounds such as picrotoxinin and syn-
thetic insecticides such as the chlorinated
cyclodienes (e.g. dieldrin, endosulfan)
(Bloomquist, 1998) and phenylpyrazoles (e.g.
ﬁpronil) (Hosie et al., 1995), act as convulsants by
blocking the inhibitory effects of GABA and pro-
ducing an indirect augmentation of excitatory
neurotransmission.
6.3.1.2. Action of pyrethroids: biochemical and
physiological eidence.T h eﬁrst report of an inter-
action of pyrethroids on GABA receptors showed
the stereospeciﬁc inhibition by deltamethrin but
not its non-toxic -R epimer of the binding of
[
3H]dihydropicrotoxinin to the convulsant (chlo-
ride channel) site of rat brain GABA receptors
(Leeb-Lundberg and Olsen, 1980). The subse-
quent development of [
35S]TBPS as an improved
radioligand for the chloride channel site of GABA
receptors led to the further documentation of the
interaction of pyrethroids with the convulsant/
chloride channel site (Lawrence and Casida, 1983;
Casida and Lawrence, 1985). These studies, em-
ploying 37 pyrethroids, documented the inhibition
of [
35S]TBPS binding by the toxic isomers of four
pyrethroids containing the -cyano-3-phenoxy-
benzyl moiety (cypermethrin, deltamethrin, fen-
valerate and ﬂuvalinate) and by isomer mixtures
of two other -cyano compounds (cyphenothrin
and fenpropathrin) but not by the non-toxic iso-
mers of -cyano compounds or by any
pyrethroids lacking the -cyano substituent. How-
ever, the original claims for absolute stereospeciﬁ-
city in these assays were contradicted by the
subsequent ﬁnding that the 1S,cis,S isomer of
cypermethrin, which has low acute toxicity to
mammals, produced signiﬁcant inhibition of
[
35S]TBPS binding to rat brain GABA receptors
(Seifert and Casida, 1985). The structure–activity
correlations for pyrethroid-dependent inhibition
of [
35S]TBPS binding led to the widely-recognized
hypothesis that -cyano pyrethroids caused the
CS intoxication syndrome by an action at the
GABA receptor–ionophore complex (Lawrence
and Casida, 1983).
Further analysis of the action of pyrethroids on
GABA receptors was undertaken using assays ofD.M. Soderlund et al. / Toxicology 171 (2002) 3–59 40
GABA receptor function. Several studies of the
effects of pyrethroids on GABA-stimulated chlo-
ride-36 uptake into brain vesicles conﬁrmed the
action of neurotoxic isomers of -cyano
pyrethroids as antagonists at mammalian brain
GABA receptors (Bloomquist and Soderlund,
1985; Abalis et al., 1986b; Bloomquist et al., 1986;
Ramadan et al., 1988c). However, the inhibition of
chloride uptake in these studies was typically in-
complete at maximally effective pyrethroid concen-
trations. Also, the incomplete stereoselectivity of
pyrethroid action on GABA receptors in these
assays was inconsistent with the profound
stereospeciﬁcity of pyrethroid toxicity. For exam-
ple, the enantiomer of deltamethrin, which is at
least 500-fold less toxic than deltamethrin, was only
10-fold less effective as an inhibitor of GABA-de-
pendent chloride uptake (Bloomquist and Soder-
lund, 1985; Bloomquist et al., 1986).
Electrophysiological assays have been employed
to assess the relative sensitivity of GABA receptors
and voltage-sensitive sodium channels expressed in
the same cell or neuronal pathway to pyrethroids.
GABA receptors in cultured dorsal root ganglion
neurons were much less sensitive to the actions of
deltamethrin than were the populations of voltage-
sensitive sodium channels expressed in the same
cells (Ogata et al., 1988). Also, electrophysiological
recordings from deﬁned GABAergic pathways in
the rat hippocampus (Gilbert et al., 1989; Joy et al.,
1989, 1990; Joy and Albertson, 1991) showed that
the effects of pyrethroids were consistent with an
augmentation of inhibition, possibly as a result of
sodium channel-mediated presynaptic excitation of
GABAergicneurons,ratherthantheantagonismof
inhibition that is typical of established blockers of
the GABA-gated chloride channel.
6.3.2. Nicotinic acetylcholine receptors
6.3.2.1. Structure and function of nicotinic acetyl-
choline receptors. The nicotinic acetylcholine recep-
tor is the mediator of fast excitatory neurotrans-
mission at vertebrate neuromuscular junctions.
Nicotinic acetylcholine receptors are also present in
the vertebrate central nervous system, but their role
in central neurotransmission is less clearly deﬁned.
In insects, nicotinic acetylcholine receptors are the
principal mediators of excitatory transmission in
the central nervous system and are an important
insecticidetargetsite.Nicotinicacetylcholinerecep-
tors are pentameric structures that form a relatively
non-selective cation channel that is opened by the
binding of acetylcholine to the receptor. Nicotinic
acetylcholine receptor subunits are encoded by a
gene family and are related structurally to GABA
receptor subunits (Vafa and Schoﬁeld, 1998).
6.3.2.2. Actions of pyrethroids: biochemical and
electrophysiological studies. An effect of
pyrethroids on nicotinic acetylcholine receptors
was initially suggested by a study showing the
inhibition of [
3H]perhydrohistrionicotoxinin (H12-
HTX) to a site associated with the channel of the
nicotinic acetylcholine receptor of electric eel elec-
troplax membranes (Abbassy et al., 1982). Further
studies with a range of pyrethroids showed that
pyrethroids inhibited both the binding of H12-HTX
to electroplax membrane receptors and receptor-
regulated calcium uptake into electroplax mem-
brane vesicles (Abbassy et al., 1983a,b). Several
non-cyano pyrethroids (allethrin, pyrethrins, te-
tramethrin,andresmethrin)weresigniﬁcantlymore
potent inhibitors of H12-HTX binding in these
assays than permethrin and several -cyano
pyrethroids (cypermethrin, fenvalerate, ﬂuvalinate,
deltamethrin, and fenpropathrin). However, the
potencies of selected pyrethroids as inhibitors of
H12-HTX binding were poorly correlated with their
potencies as inhibitors of receptor-regulated cal-
cium uptake. Further, the inhibition of receptor-
regulated calcium uptake by allethrin and
fenvalerate could not be reproduced in assays of
receptor-activated sodium uptake (Sherby et al.,
1986). Finally, studies of acetylcholine-gated cur-
rents in voltage-clamped N1E-115 neuroblastoma
cells showed that [1R,cis]-cyphenothrin, [1R,cis]-
fenﬂuthrin, and [1S,cis]-fenﬂuthrin blocked both
acetylcholine- and serotonin-induced currents
through effects on separate receptors for
these ligands, but the concentration required to
produce such effects was in excess of the concentra-
tions of [1R,cis]-cyphenothrin and the neurotoxic
1R,cis isomer of fenﬂuthrin to modify sodium
channelfunctioninthesamecells(Oortgiesenetal.,
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6.3.3. Excitatory glutamate receptors
6.3.3.1. Structure, function and diersity of gluta-
mate receptors. In the vertebrate central nervous
system, excitatory glutamate receptors mediate
the fast synaptic action of L-glutamate, a major
excitatory neurotransmitter (Sprengel and See-
burg, 1995). These complexes form relatively non-
selective cation-selective channels that are
permeable to calcium and sodium, and are essen-
tial components of synaptic function and plastic-
ity in the brain. Disruptions of glutamatergic
neurotransmission is involved in excitotoxicity
that is associated with local brain damage due to
deﬁcient blood ﬂow. Glutamate receptors are also
implicated in epileptic discharge and play an im-
portant role in long-termed potentiation.
Excitatory glutamate receptor-channel com-
plexes are heteromultimers formed from subunits
that are structurally related to subunits of nico-
tinic acetylcholine and the GABA receptors
(Sprengel and Seeburg, 1995). Excitatory gluta-
mate receptor-channel complexes are classiﬁed on
the basis of their agonist pharmacology into ﬁve
major classes: the N-methy-D-aspartate; kainate;
-amino-3-hydroxy-5-methyl-4-isoxazole propi-
onate; 2-amino-4-phosphonobutanoate and trans-
1-amino-cyclopentyl-1,3-decarboxylate receptors.
Of these, the N-methyl-D-aspartate receptors
form ion channels that are primarily permeable to
calcium, whereas the other glutamate receptor
classes form channels that preferentially transport
sodium ions.
6.3.3.2. Action of pyrethroids on glutamate recep-
tors. The initial evidence for an action of
pyrethroids on glutamate receptors was obtained
in binding assays with [
3H]kainate, which labels
one class of glutamate receptors. In these studies,
both cis-permethrin and deltamethrin inhibited
[
3H]kainate binding in mouse brain preparations
(Staatz et al., 1982). Allethrin, deltamethrin and
fenvalerate also blocked N-methy-D-aspartate-de-
pendent calcium currents in rat hippocampal and
neocortical neurons (Frey and Narahashi, 1990).
In contrast to these ﬁndings, assays with guinea
pig olfactory cortex slices did not detect any
effects of deltamethrin or fenvalerate on excita-
tory glutamate receptors in this preparation
(Narahashi, 1987).
6.4. Actions of pyrethroids on other biochemical
targets
6.4.1. Peripheral-type benzodiazepine receptors
6.4.1.1. Function and pharmacology of peripheral-
type benzodiazepine receptors. Benzodiazepines ex-
ert their therapeutic effects primarily as a result of
their actions on the GABA receptor complex (see
Section 6.3.1.1). However, studies of the binding
of the benzodiazepine radioligand [
3H]diazepam
in rat tissue preparations identiﬁed high afﬁnity
binding sites in peripheral, non-neuronal tissues
that lacked GABA receptors (Braestrup and
Squires, 1977). Subsequent studies showed that
this second class of benzodiazepine binding sites
(called ‘peripheral-type benzodiazepine receptors’)
could be distinguished from benzodiazepine bind-
ing sites associated with the GABA receptors by
its pharmacological proﬁle, tissue distribution,
and subcellular localization (Zisterer and
Williams, 1997). In contrast to diazepam, which
binds to both classes of benzodiazepine binding
sites with relatively high afﬁnity, the ligands Ro5-
4864 and PK11195 speciﬁcally label the periph-
eral-type benzodiazepine receptor.
The structure and function of the peripheral-
type benzodiazepine receptor remain incompletely
characterized (Zisterer and Williams, 1997). This
receptor is associated with the mitochondrial
outer membrane and appears to be associated
with the voltage-dependent anion channel
(‘porin’). Although, a variety of physiological and
biochemical effects have been attributed to pe-
ripheral-type benzodiazepine receptor ligands
(Zisterer and Williams, 1997), the most relevant
from the perspective of this review are the convul-
sant and proconvulsant effects of Ro5-4864 and
the speciﬁc antagonism of these effects by
PK11195 (Benavides et al., 1984).
6.4.1.2. Actions of pyrethroids: biochemical studies.
Biochemical evidence for the action of -cyano
pyrethroids on GABA receptors (see Section
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effects of pyrethroids on the binding of benzodi-
azepine radioligands in brain preparations. Initial
studies with [
3H]Ro5-4864, performed under the
assumption that this ligand labeled a site associ-
ated with the GABA receptor complex, showed
that both deltamethrin and the insecticidal and
neurotoxic 1R,cis,S isomer of cypermethrin were
potent inhibitors of Ro5-4864 binding in rat brain
synaptic membranes, whereas fenvalerate, perme-
thrin, allethrin, and the remaining seven isomers
of cypermethrin were all at least 15-fold less po-
tent inhibitors of Ro5-4864 binding (Lawrence et
al., 1985). Two subsequent studies examined a
total of 15 pyrethroids as inhibitors of [
3H]Ro5-
4864 binding to rat brain preparations (Devaud
and Murray, 1988; Ramadan et al., 1988b). These
studies conﬁrmed that pyrethroids inhibited the
binding of this ligand with IC50 values ranging
from 40 nM to 100 M. Most of the -cyano
pyrethroids examined were more potent than the
non-cyano pyrethroids in these studies, but this
generalization did not extend to fenvalerate and
ﬂuvalinate. These studies also conﬁrmed that only
the 1R,cis,S isomer of cypermethrin was an ef-
fective inhibitor and that the insecticidal and neu-
rotoxic 1R,cis isomer of permethrin was much
more effective than the inactive 1S,cis isomer.
6.4.1.3. Action of pyrethroids: pharmacological
studies in io. Studies with rats in vivo explored
the possible actions of pyrethroids at the
peripheral-type benzodiazepine receptor using
the potentiation of pentylenetetrazole-induced
seizures as an experimental model system. Initial
studies showed that [1R,cis,S]-cypermethrin,
deltamethrin, fenvalerate, and permethrin acted as
proconvulsants in this system, producing a dose-
dependent lowering of the dose of pentylenetetra-
zole required to induce seizures, but the non-toxic
enantiomer of [1R,cis,S]-cypermethrin was com-
pletely ineffective (Devaud and Murray, 1986).
The actions of pyrethroids in these experiments
were similar to the proconvulsant (seizure-potenti-
ating) effects of Ro5-4864 in rodents (Benavides
et al., 1984). The maximal pyrethroid-dependent
reduction in the pentylenetetrazole seizure
threshold occurred at intraperitoneal doses of
pyrethroid that were too low causing the charac-
teristic signs of pyrethroid-induced intoxication
(Devaud and Murray, 1986). PK11195, which an-
tagonizes the proconvulsant activity of Ro5-4864
(Benavides et al., 1984), also antagonized the pro-
convulsant effects of deltamethrin and perme-
thrin, thereby implicating an action of pyrethroids
at the peripheral-type benzodiazepine receptor. A
second study by the same research group (Devaud
and Murray, 1988) extended these observations to
include ﬁve additional non-cyano pyrethroids (al-
lethrin, cismethrin, kadethrin, resmethrin and te-
tramethrin) and the 1R,cis and 1S,cis isomers of
permethrin. All of the compounds tested except
allethrin and [1S,cis]-permethrin were active as
proconvulsants in this assay. Moreover, PK11195
also antagonized the proconvulsant effects of cis-
methrin. In contrast to these ﬁndings, a subse-
quent study by other researchers (Gilbert et al.,
1990) did not conﬁrm the high potency of either
cismethrin or deltamethrin assays of proconvul-
sant activity using the pentylenetetrazole or amyg-
dala kindling seizure models.
6.4.2. Mediators of ion channel and receptor
regulation
6.4.2.1. Biochemistry of ion channel and receptor
regulation. Neuronal excitability, both within and
between neurons, is tightly regulated. Ion chan-
nels and neurotransmitter receptors undergo
phosphorylation and dephosphorylation by
protein kinases and phosphatases, respectively,
and interact with G protein subunits (Catterall,
1997; Conley and Brammar, 1999). Kinases, phos-
phatases, and G proteins are regulated in turn by
pathways that involve diacylglycerols, inositol
phosphates and intracellular calcium. These
events mediate ion channel and receptor up- and
down-regulation, modify the kinetics of voltage-
sensitive channels, and regulate receptor desensi-
tization to maintain the integrity of signaling
pathways in the nervous system. Agents that
modify these regulatory pathways exert both di-
rect and indirect effects on ion channel and recep-
tor function.
6.4.2.2. Effects of pyrethroid action on ion channel
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effects of pyrethroids on protein phosphorylation
patterns in invertebrate nerve and mammalian
brain preparations (Clark, 1986; Gusovsky et al.,
1986; Matsumura, 1986; Gusovsky et al., 1988;
Matsumura, 1988; Ishikawa et al., 1989; Mat-
sumura et al., 1989; Clark and Matsumura, 1991;
Enan and Matsumura, 1991; Kanemoto et al.,
1992; Enan and Matsumura, 1993). These results
are supported by studies documenting effects of
pyrethroids on second messenger pathways that
regulate kinase and phosphatase activity. For ex-
ample, deltamethrin stimulated phosphatidylinosi-
tol turnover in guinea pig brain and resulted in
increased levels of diacylglycerols and inositol
polyphosphates (Gusovsky et al., 1986; Gusovsky
and Daly, 1988; Gusovsky et al., 1989). Other
experiments using rat brain slices showed that
deltamethrin at concentrations as low as 10
−10 M
increased the levels of inositol polyphosphate for-
mation, increased intracellular free calcium, in-
creased calcium/diacylglycerol-dependent kinase
activity and speciﬁc protein phosphorylations re-
lated to neurotransmitter release (Enan and Mat-
sumura, 1993). Most interesting, however, was the
increased recruitment of calcium/diacylglycerol-
dependent kinase to the plasma membrane frac-
tion versus the cytosol in the presence of
deltamethrin, cypermethrin, fenvalerate and al-
lethrin. In Paramecium, it has been recently estab-
lished that deltamethrin signiﬁcantly and
stereospeciﬁcally increased the G protein  sub-
unit-dependent phospholipase C activity in ciliary
membrane vesicles, as determined by increased
inositol polyphosphate production (Symington et
al., 1999).
Pyrethroids also bind directly to the  subunits
of G proteins (Rossignol, 1991a). A photoreactive
fenvalerate analog that possessed insecticidal ac-
tivity labeled a 36-kDa protein that was identiﬁed
as the  subunit of G protein. Labeling was
increased by GTP-S, a non-hydrolyzable analog
of GTP that persistently liberates / and  sub-
units, and treatment with the photoreactive fen-
valerate analog resulted in the dissociation of the
G protein subunits as measured by ADP-ribosyla-
tion of the  subunit (Rossignol, 1991b).
6.4.3. Mitochondrial electron transport
Mitochondrial electron transport is central
to the energy metabolism of all eukaryotic
cells. The literature describing the action of
pyrethroids on mitochondrial respiration is
sparse. Allethrin has been shown to perturb the
light scattering properties of mouse liver
mitochondria and increase mitochondrial respira-
tion (Settlemire et al., 1974). Also, fenvalerate
affected oxygen consumption in ﬁsh (Reddy et al.,
1992) and cypermethrin (Ghosh et al., 1989) in-
hibited ﬁsh liver mitochondrial enzymes
involved in cellular respiration. Recently, perme-
thrin and cyhalothrin were shown to be
potent inhibitors of respiratory complex I, the
rotenone sensitive complex, from rat liver mito-
chondria (Gassner et al., 1997). Assays with sub-
mitochondrial particles demonstrated that
complex I was the sensitive site within the respira-
tory chain having the greatest sensitivity to
pyrethroids.
6.5. Critical ealuation of putatie mechanisms of
action
6.5.1. Criteria for the assessment of releant
mechanisms of toxicity
6.5.1.1. Functional relationship to pyrethroid intox-
ication. A fundamental criterion for assessing the
relevance of any proposed mechanism of
pyrethroid action is whether or not this mecha-
nism is consistent with the signs of pyrethroid
intoxication. The acute effects of pyrethroids in
mammals are neuroexcitatory, involving enhanced
sensitivity to external stimuli, tremor, and convul-
sions. When pyrethroids are administered intrac-
erebrally or intravenously, these signs develop
very rapidly. Pyrethroid intoxication is therefore
likely to occur by mechanisms that mediate a
direct, excitatory effect on the nervous system. In
contrast, mechanisms that result in a decrease in
neuronal excitation, or those which involve
slowly-developing but longer-term changes in neu-
ronal excitability, are not consistent with the signs
and time course of acute intoxication by
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6.5.1.2. Structure–actiity relationships. The struc-
ture and three-dimensional conﬁguration of
pyrethroids are critical determinants of both in-
secticidal activity and acute toxicity to mammals.
In particular, pyrethroid action is highly
stereospeciﬁc: typically, mixtures of four or eight
optical and geometrical isomers of a pyrethroid
contain only one or two active isomers, and the
remaining isomers have toxicities so low that they
are difﬁcult to measure accurately. The stereospe-
ciﬁc effects of pyrethroids are not explained by
differential detoxication and are observed upon
direct introduction of pyrethroids into the verte-
brate central nervous system. We therefore con-
clude that toxicologically relevant sites of
pyrethroid action must exhibit the stereospeciﬁc-
ity that is evident in pyrethroid intoxication. Al-
though stereospeciﬁcity is an essential criterion
for toxicological relevance, it is not the sole crite-
rion: whereas all toxicologically relevant sites
must be stereospeciﬁc, not all stereospeciﬁc ac-
tions of pyrethroids are necessarily toxicologically
relevant.
Other structure–activity relationships evident
in pyrethroid intoxication are less absolute than
those based on stereochemistry and must be used
with greater caution in evaluating proposed mech-
anisms of action. The division of pyrethroids into
two broad structural and functional classes (-
and non-cyano pyrethroids) has received wide
acceptance in the literature and is supported to a
degree by the pharmacological and toxicological
properties of these two groups of compounds.
Candidate sites of pyrethroid action (e.g. voltage-
sensitive chloride channels) that are preferentially
sensitive to a subset of pyrethroids, and which
also conform to the other criteria for toxicological
relevance, may play a role in the divergent signs
of pyrethroid intoxication.
6.5.1.3. Potency. The criterion of potency is par-
ticularly difﬁcult to apply to a class of compounds
such as the pyrethroids, which are extremely
lipophilic and preferentially associate with biolog-
ical membranes and other lipid-rich physiological
compartments. For in vivo studies, these proper-
ties render circulating levels of pyrethroid unreli-
able as indices of the amount of compound
available to membrane-bound targets in the ner-
vous system. For in vitro studies, concentrations
of applied pyrethroid are difﬁcult to compare
from system to system due to the nature of the
biological preparation used, the co-solvents em-
ployed to achieve an aqueous ‘solution’ of
pyrethroid, and the method and duration of
pyrethroid exposure.
Despite these difﬁculties, considerations of po-
tency may assist the evaluation of toxicological
relevance of candidate pyrethroid target sites in
three ways. Actions of pyrethroids on speciﬁc
targets identiﬁed in in vivo experiments may be
considered to be potentially toxicologically rele-
vant if they can be demonstrated to occur at doses
of pyrethroids that produce signs of intoxication.
In most cases, evidence for such effects is based
on the pharmacological antagonism of one or
more signs of pyrethroid intoxication by agents
having deﬁned modes of action. Alternatively,
toxicological relevance may be established in ex
vivo experiments, in which the disruption of a
candidate target is documented by biochemical or
physiological techniques in vitro following expo-
sure of the animal at a toxicologically relevant
pyrethroid dose in vivo. For in vitro experiments,
the usefulness of potency as a criterion of toxico-
logical relevance is limited to those systems in
which two putative target sites can be assayed
simultaneously in the same preparation. If one
such target can be established by other criteria to
be toxicologically relevant, then the relative sensi-
tivity of the second candidate target may provide
insight into the probability that an effect at that
site contributes meaningfully to intoxication.
6.5.2. Ealuation of putatie mechanisms of
toxicity
6.5.2.1. Voltage-sensitie sodium channels.
Voltage-sensitive sodium channels are well-estab-
lished as the principal site of insecticidal action of
pyrethroids, and many lines of evidence implicate
voltage-sensitive sodium channels as an important
site of pyrethroid action in mammals. The effects
of pyrethroids on sodium channel function are
consistent with a mechanism involving enhanced
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the stereospeciﬁcity anticipated for a toxicologi-
cally relevant effect. Moreover, the differences
observed in the modiﬁcation of sodium channels
by - and non-cyano pyrethroids are consistent
with the differences in the disruption of nerve
action potentials caused by members of these two
structural groups and with the production of CS
and T syndromes of intoxication in vivo. How-
ever, the results of biophysical experiments sug-
gest that the division of - and non-cyano
pyrethroids into two distinct functional classes
represents an oversimpliﬁcation, because biophys-
ical studies identify a spectrum of pyrethroid ef-
fects on sodium channel function that are
correlated with the production of signs of poison-
ing that are intermediate between the T and CS
syndromes.
The emerging picture of mammalian voltage-
sensitive sodium channels as products of a multi-
gene family complicates the interpretation of the
action of pyrethroids on sodium channels. Lim-
ited evidence from physiological experiments in
vitro and from assays with cloned sodium channel
isoforms suggest that different sodium channel
isoforms vary in their sensitivity to pyrethroids as
a class as well as to compounds representative of
the - and non-cyano structural classes. However,
information on the relative sensitivity of sodium
channel isoforms to pyrethroids is incomplete,
making it impossible at present to identify those
isoforms that are most sensitive to pyrethroids as
a class and those with differential sensitivity to
pyrethroids that might contribute to the produc-
tion of different signs of intoxication in vivo.
6.5.2.2. Voltage-sensitie calcium channels. A sub-
stantial body of evidence from electrophysiologi-
cal and biochemical studies in vitro shows that
pyrethroids affect calcium channel function.
Pyrethroids are antagonists of T-type calcium
channels in vertebrate tissues and agonists of T-
type channels in insect muscle and in the ciliary
membrane of P. tetraurelia. Actions of
pyrethroids on N-type calcium channels also are
implicated indirectly by the ﬁnding that
pyrethroid-stimulated neurotransmitter release is
not completely abolished in some studies under
experimental conditions that eliminate effects on
sodium channels. However, a direct effect of
pyrethroids on currents carried by N-type calcium
channels has not been reported. Pyrethroid ac-
tions in these assays exhibit appropriate stereospe-
ciﬁcity for the isomer pairs that have been
examined. Electrophysiological and biochemical
evidence suggests that L-type calcium channels
are relatively insensitive to pyrethroids, but other
types of calcium channels have not been investi-
gated for their sensitivity to pyrethroids. Al-
though numerous calcium channel 1 subunits
have been cloned, only some of these have been
expressed functionally and the assays of
pyrethroids on identiﬁed calcium channel iso-
forms, analogous to assays with cloned sodium
channel isoforms, have not been performed.
Although an action of pyrethroids on N-type
calcium channels is consistent with the massive
neurotransmitter release caused by pyrethroid in-
toxication in vivo, there is no evidence from phar-
macological studies in vivo that illuminates the
role of calcium channels in intoxication. However,
the observation of effects of pyrethroids on cal-
cium channels in neurotransmitter release assays
in vitro suggests that effects on calcium channels
may contribute to intoxication.
6.5.2.3. Voltage-sensitie chloride channels.T h e
action of pyrethroids on voltage-sensitive chloride
channels has been postulated to be an effect lim-
ited to compounds in the -cyano structural
group, but this conclusion is based on experi-
ments with deltamethrin as the sole example of
the -cyano class and cismethrin as the sole exam-
ple of the non-cyano class. The blockade of
voltage-dependent chloride channels by
deltamethrin would contribute to the excitation of
nerve and muscle in combination with other neu-
roexcitatory effects and is therefore consistent
with the overall neuroexcitatory actions of
pyrethroids. At present, the stereospeciﬁcity of the
action of pyrethroids on this target is not known.
Additional evidence for the toxicological rele-
vance of pyrethroid actions on voltage-sensitive
chloride channels comes from pharmacological
studies in vivo. Both ivermectin and pentobarbi-
tal, which selectively activate voltage-dependent
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deltamethrin intoxication and reduced the inci-
dence of lethality at the deltamethrin doses em-
ployed but did not similarly affect cismethrin
intoxication (Ray et al., 1999; Forshaw et al.,
2000). The effects of these agents on salivation
and the motor signs of intoxication caused by
deltamethrin appeared to be due to antagonism of
the action of deltamethrin at peripheral and cen-
tral nervous system chloride channels, respec-
tively. However, the protection against lethality
afforded by pentobarbital could not be distin-
guished from the similar effects of phenobarbital,
which is a poor activator of chloride channels,
and may therefore result from the overall depres-
sant actions of barbiturates at other sites. Despite
the limited number of pyrethroids used in these
studies, the results suggest that actions at voltage-
sensitive chloride channels may contribute to
some of the signs of intoxication associated with
the CS poisoning syndrome.
6.5.2.4. GABA receptors. A large body of bio-
chemical evidence documents the ability of -cy-
ano pyrethroids to bind to and block GABA
receptors in mammalian brain preparations.
Blockade of GABA receptors is an indirect neu-
roexcitatory effect, involving the removal of in-
hibitory neuronal input, and is the established
mode of action for convulsants such as picrotox-
inin. From a functional point of view, an action
on GABA receptors is therefore consistent with
the neuroexcitatory signs of pyrethroid intoxica-
tion in vivo. The action of pyrethroids on GABA
receptors is somewhat stereoselective for neuro-
toxic isomers of -cyano compounds but does not
exhibit the absolute stereospeciﬁcity predicted by
structure–toxicity relationships. In experimental
systems where effects on GABA receptors and
sodium channels can be assayed in the same
preparation, GABA receptor blockade is not ob-
served at concentrations of pyrethroid that dis-
rupt sodium channel function.
There is only a limited amount of information
correlating the in vitro biochemical effects of
pyrethroids on GABA receptors with intoxication
in vivo. The initial description of the T and CS
intoxication syndromes following intracerebral
administration of pyrethroids to mice noted that
the CS syndrome was similar to the signs of
intoxication produced by the intracerebral admin-
istration of picrotoxinin (Lawrence and Casida,
1982). The ability of diazepam, a benzodiazepine
known to act at GABA receptors, to increase the
latency of the CS syndrome and to antagonize the
acute intracerebral toxicity of deltamethrin and
the neurotoxic isomer of fenvalerate more than
10-fold was also interpreted as evidence for an
action at GABA receptors in the production of
the CS syndrome (Gammon et al., 1982). How-
ever, the relatively low potency and incomplete
stereospeciﬁcity of pyrethroids as GABA receptor
antagonists in functional assays do not support an
action at the GABA receptor as a signiﬁcant
target site involved in the production of the CS
intoxication syndrome.
6.5.2.5. Acetylcholine receptors. The possible in-
volvement of acetylcholine receptors in pyrethroid
intoxication is based on the ability of certain
pyrethroids, principally non-cyano compounds, to
inhibit the binding of the ligand H12-HTX to
acetylcholine receptors in eel electroplax prepara-
tions. Analysis of the effect of pyrethroids on
acetylcholine receptors and other ligand-gated
cation channels in cultured N1E-115 neuroblas-
toma cells revealed that receptor blockade, the
effect predicted from binding studies, was not
appropriately stereospeciﬁc and also was not spe-
ciﬁc for acetylcholine receptors. Moreover, block-
ade of cholinergic neurotransmission would not
cause or contribute to neuroexcitation. We con-
clude that the action of pyrethroids on nicotinic
acetylcholine receptors in vitro is not likely to be
relevant to intoxication in vivo.
6.5.2.6. Excitatory glutamate receptors. The evi-
dence for an action of pyrethroids on glutamate
receptors is very limited and somewhat con-
tradictory. In the absence of structure–activity
data correlating effects on glutamate receptors in
vitro with intoxication in vivo or pharmaco-
logical evidence of glutamate receptor effects in
intoxication, we conclude that a toxicologically
relevant effect of pyrethroids on this target is
unlikely.D.M. Soderlund et al. / Toxicology 171 (2002) 3–59 47
6.5.2.7. Peripheral-type benzodiazepine receptors.
A variety of pyrethroids, including both non- and
-cyano compounds, inhibit the binding of the
ligand Ro5-4864 to peripheral-type benzodi-
azepine receptors. Given that Ro5-4864 is a con-
vulsant, competitors for this site are also
potentially convulsants, although there is no in
vitro assay for peripheral-type benzodiazepine re-
ceptor function. For the isomer pairs that have
been examined, the inhibition of Ro5-4864 binding
exhibits a degree of stereospeciﬁcity that is consis-
tent with the stereospeciﬁcity of pyrethroid intoxi-
cation.
Evidence for the involvement of effects on pe-
ripheral-type benzodiazepine receptors in intoxica-
tion comes from pharmacological studies in vivo.
Pyrethroids at doses below those that produce
signs of intoxication potentiate the convulsant
actions of pentylenetetrazole in a manner similar
to Ro5-5864, and these proconvulsant effects are
blocked by PK11195, a speciﬁc antagonist of Ro5-
4864 at the peripheral-type benzodiazepine recep-
tor. These results provide evidence for the
interaction of pyrethroids with the peripheral-type
benzodiazepine receptor, but this effect cannot be
a primary mechanism of intoxication because it
occurs at pyrethroid doses that are without effect
outside of the proconvulsant experimental model.
Moreover, it should be noted that the potent
proconvulsant actions of cismethrin and
deltamethrin could not be reproduced by other
researchers.
Despite the contradictory nature of the results
obtained in vivo, it is possible that the action of
pyrethroids at the peripheral-type benzodiazepine
receptor contributes to pyrethroid intoxication by
enhancing convulsions arising due to neuroexcita-
tory effects at other target sites. Some support for
this interpretation comes from the ability of di-
azepam to increase the latency of pyrethroid intox-
ication (Gammon et al., 1982). This effect was
originally interpreted as evidence for an effect of
pyrethroids at GABA receptors; however, di-
azepam binds with high afﬁnity to both GABA
receptors and peripheral-type benzodiazepine re-
ceptors in rodents. Thus, the effects of diazepam
on the latency of pyrethroid intoxication may
more plausibly result from antagonism at the
peripheral-type benzodiazepine receptor rather
than at the GABA receptor. We consider that
some pyrethroids may act as proconvulsants at
peripheral-type benzodiazepine receptors at toxi-
cologically relevant doses, but the relationship of
such an effect to the primary neuroexcitatory
actions of pyrethroids and its contribution to the
signs of pyrethroid intoxication remain to be
elucidated.
6.5.2.8. Ion channel and receptor regulation. Several
lines of evidence point to the ability of pyrethroids
to modify second messenger pathways involved in
ion channel and neurotransmitter receptor regula-
tion. Moreover, pyrethroids appear to exert spe-
ciﬁc effects on the pattern of protein
phosphorylation in neurons. Although some of
these effects represent neuronal responses to the
neuroexcitatory actions of pyrethroids rather than
primary mechanisms of toxicity, others may reﬂect
a more speciﬁc action of pyrethroids. In view of
the direct modulation of N-, P-, and T-type cal-
cium channels by  subunits of G proteins, the
binding of pyrethroids to the  subunit implied
by the results of photoafﬁnity labelling experi-
ments could result in effects on a number of
macromolecules, including sodium and calcium
channels. At present, these effects are limited to
observations from in vitro experiments and are not
directly correlated with pyrethroid intoxication in
vivo.
6.5.2.9. Mitochondrial electron transport. The evi-
dence for an action of pyrethroids on mitochon-
drial electron transport is very limited. However,
the syndromes of pyrethroid intoxication in vivo
are distinct from the well-characterized toxic ac-
tions of respiratory inhibitors and uncouplers. We
therefore conclude that a toxicologically important
action of pyrethroids on this target is unlikely.
7. Conclusions
7.1. Pyrethroid toxicity
Most pyrethroids are moderately toxic (EPA
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observed following acute or subchronic exposure
of mammals to pyrethroids as a class are various
signs of excitatory neurotoxicity. In contrast,
there is no evidence that other effects of
pyrethroids, involving either acute effects on other
organ systems or chronic effects, are characteristic
of pyrethroids as a class (Clark, 1995). Therefore,
consideration of common mechanisms among
pyrethroids is appropriately focused on those
mechanisms that are responsible for the acute
neurotoxicity of these compounds.
Physiological and neurochemical studies of
pyrethroid-intoxicated animals conﬁrm that acute
pyrethroid intoxication is associated with altered
nerve function, principally involving neuroexcita-
tory effects, in the brain, spinal cord, and ele-
ments of the peripheral nervous system.
Although, differences in sensitivity between brain
regions are evident, there is no single region of the
nervous system that is the locus of pyrethroid
intoxication and identiﬁes a mechanism of toxic
action.
Despite their lipophilicity, pyrethroids do not
bioaccumulate in lipid-rich tissues because they
are readily metabolized by hydrolases and cy-
tochrome P450-dependent monooxygenases in the
liver and other tissues. The metabolites of
pyrethroids are typically of lower toxicity
than the parent compound and are readily ex-
creted. The toxicokinetic proﬁles of parent
pyrethroids following single oral doses are consis-
tent with the onset and duration of signs of
intoxication.
Structure–activity relationships for both
the insecticidal activity and the acute mammalian
toxicity of pyrethroids show that activity is
determined by the overall shape, three-
dimensional conﬁguration, and physical proper-
ties of the parent compound. The structural
diversity of commercially used pyrethroids
illustrates that requirement for pyrethroid-like ac-
tivity can be met by a variety of chemical struc-
tures. Unlike organophosphate or methyl-
carbamate insecticides, which contain a speciﬁc
chemical moiety that both deﬁnes each class
chemically and functions as a toxophore,
there is no single essential chemical moiety that is
required to obtain pyrethroid-like insecticidal ac-
tivity or cause pyrethroid-like mammalian
toxicity.
7.2. Syndromes of pyrethroid intoxication
Historically, pyrethroids were grouped into two
subclasses (commonly designated ‘Type I’ and
‘Type II’) based on chemical structure and the
production of either the T (tremor) or CS
(choreoathetosis with salivation) intoxication syn-
drome following intravenous administration to
rats or intracerebral administration to mice. Al-
though, this classiﬁcation system is widely recog-
nized and employed, it has several shortcomings
for the identiﬁcation of common toxic effects
among pyrethroids. First, this classiﬁcation did
not include several pyrethroids that are currently
registered for use in the United States. Because
the production of the T and CS syndromes was
not unambiguously correlated with chemical
structure, the extension of this taxonomy to com-
pounds not included in the original studies would
require empirical evaluation of each compound by
methods comparable to those employed in the
classiﬁcation studies. Second, the T and CS cate-
gories identiﬁed in these studies were not absolute
and mutually exclusive, because some compounds
were identiﬁed that exhibited elements of both
syndromes. Third, the T and CS syndromes were
deﬁned using routes of exposure (i.e. intravenous
or intracranial) that are of limited relevance to
risk assessment for human exposure to pyrethroid
residues. Finally, the diversity of intoxication
signs found in acute and subchronic neurotoxicity
studies, which involve oral administration, are
not congruent with those that form the basis of
the historical classiﬁcation of intoxication syn-
dromes.
7.3. Mechanisms of pyrethroid toxicity
A large body of published literature describes
the actions of pyrethroids in vitro on a variety of
putative biochemical and physiological target
sites. These studies vary in technical quality,
depth, and relevance to an understanding of the
toxic actions of pyrethroids in animals. Our criti-
cal analysis identiﬁed four target sites that meritD.M. Soderlund et al. / Toxicology 171 (2002) 3–59 49
consideration as sites of toxic action of
pyrethroids. First, there is ample evidence that
voltage-sensitive sodium channels, the sites of in-
secticidal action of pyrethroids, are also impor-
tant target sites in mammals. Mammals, unlike
insects, have multiple sodium channel isoforms
that vary in their biophysical and pharmacologi-
cal properties, including their sensitivity to some
or all pyrethroids. Therefore, it is not appropriate
to consider ‘the mammalian sodium channel’ as a
single, pharmacologically homogeneous target site
for pyrethroids. Moreover, where the combined
actions of different pyrethroids on sodium chan-
nels have been examined, these effects are not
additive and may be antagonistic.
There is also experimental evidence for the ac-
tion of pyrethroids at three other sites that may
contribute to intoxication in vivo. Pyrethroids
have been shown to act on some isoforms of the
voltage-sensitive calcium channel, an effect that
may contribute to the release of neurotransmitters
that is associated with pyrethroid intoxication.
Blockade of voltage-sensitive chloride channels by
some pyrethroids is associated with the produc-
tion of salivation, a hallmark of the CS intoxica-
tion syndrome, and may also contribute to
enhanced excitability in the central nervous sys-
tem. Effects on peripheral-type benzodiazepine
receptors are unlikely to be a principal cause of
pyrethroid intoxication but may contribute
to or enhance convulsions caused by actions at
other target sites. In contrast, other putative
target sites for pyrethroid action that have been
identiﬁed in in vitro experiments (e.g. GABA
receptors, nicotinic acetylcholine receptors) do not
appear to play a major role in pyrethroid intoxi-
cation.
7.4. Implications for cumulatie risk assessment
7.4.1. Risk of exposure to multiple pyrethroids
The cumulative risk assessment of pyrethroids
is complicated by several factors. First, the exis-
tence of multiple target sites with differing phar-
macological proﬁles raises the question of which
target should be employed in the assessment of
the effects of multiple compounds. This problem
of multiple, pharmacologically distinct targets re-
mains even if one only considers voltage-sensitive
sodium channels as sites of action, but it is exacer-
bated by possible involvement of other function-
ally and pharmacologically distinct targets in
pyrethroid intoxication at the level of the whole
animal (e.g. voltage-sensitive calcium and chloride
channels).
Second, pyrethroids differ not only in their
relative potency but also in the qualitative nature
of their effects at some targets. Considering
voltage-sensitive sodium channels as an example
target for which extensive data exist, the pro-
foundly different lifetimes of the pyrethroid-
modiﬁed open states caused by compounds such
as tetramethrin (short) or deltamethrin (very long)
produce profoundly different effects (burst dis-
charges or use-dependent block, respectively) at
the level of the intact nerve. There are no data
available to determine whether equivalent frac-
tional occupancy of binding sites by compounds
such as tetramethrin and deltamethrin produces
an equivalent disruption of nerve function given
the divergent qualitative effects of these com-
pounds on any single isoform of the voltage-sensi-
tive sodium channel and the divergent
consequences for nerve function that ensue.
Third, an implicit assumption of cumulative
risk assessment is that the effects of two com-
pounds acting by the same mechanism at the same
macromolecular target are, at a minimum, addi-
tive or perhaps synergistic. In the case of the
action of pyrethroids on sodium channels, there is
experimental evidence that binary interactions are
potentially subadditive or antagonistic, so that the
presence of a second compound displaces or can-
cels the action of a previously administered
compound.
We conclude from these considerations that
simple additivity models to assess the risks of
combined exposure to multiple agents are not
appropriate to the pyrethroids. Such models do
not account for the multiplicity of targets, the
qualitative differences that distinguish the actions
of different pyrethroids at some targets, and the
potential for non-additive effects of two or more
compounds at the same target.D.M. Soderlund et al. / Toxicology 171 (2002) 3–59 50
7.4.2. Risk of combined exposure to pyrethroids
and other classes of pesticides
Because human exposure to pyrethroids occurs
in the context of concurrent exposure to other
environmental chemicals and pharmaceutical
agents, it is necessary to consider the possibility
that pyrethroids may share common toxic effects
and mechanisms with other chemically- and func-
tionally-unrelated substances. Some of the puta-
tive sites of action for pyrethroids are known sites
of action of other substances.
Voltage-sensitive sodium channels are targets
for the bioactivation product of the novel insecti-
cide indoxacarb and for experimental pyrazoline
insecticides that are part of the same structure–
activity group (McCann et al., 2001). These com-
pounds block ion transport through sodium
channels, an action that is antagonistic to the
prolongation of sodium channel opening that is
caused by pyrethroids (Payne et al., 1998; Wing et
al., 1998). Since indoxacarb and pyrethroids pro-
duce different and opposite effects on sodium
channels that are mediated by different binding
sites on the sodium channel protein (Soderlund
and Knipple, 1995), they therefore do not merit
grouping on the basis of a common mechanism.
A similar situation exists in the case of voltage-
sensitive chloride channels, which are important
target sites for avermectin insecticides. Aver-
mectins activate voltage-sensitive chloride chan-
nels (Abalis et al., 1986a; Payne and Soderlund,
1991), an effect that is opposite to the channel-
blocking effect found for some pyrethroids. More-
over, an avermectin analog has been shown to
antagonize in vivo some of the effects of
pyrethroids that are thought to be mediated by an
action on voltage-sensitive chloride channels (For-
shaw et al., 2000). Because avermectins and
pyrethroids produce different and opposite effects
on chloride channels, they should not be grouped
based on their actions at this target.
GABA receptors are target sites for several
insecticides, including chlorinated cyclodienes
(e.g. endosulfan) and phenylpyrazoles (e.g.
ﬁpronil) (Bloomquist, 1993b, 1996, 1998). Al-
though pyrethroids bind to and affect GABA
receptors in vitro, we conclude that these effects
are not likely to be relevant to intoxication in
vivo. A similar situation exists for nicotinic acetyl-
choline receptors, which are sites of action of
chloronicotinoid insecticides (e.g. imidacloprid)
(Nagata et al., 1998). Although pyrethroids dis-
place the binding of a ligand that labels nicotinic
acetylcholine receptors, there is no evidence that
this effect is correlated with a change in receptor
function or is related in any way to intoxication in
vivo. These considerations suggest that
pyrethroids do not act at either GABA or nico-
tinic acetylcholine receptors in a manner that
would cause them to be grouped on the basis of
common mechanism with other insecticides that
are known to act at either of these targets.
We conclude from the foregoing that the puta-
tive sites of action of pyrethroids that are most
likely to be involved in the production of acute
neurotoxic effects are not shared with other
classes of pesticides. Therefore, the effects of
pyrethroids at these sites, to the extent that such
effects are actually involved in pyrethroid toxicity,
are not relevant to cumulative risk assessments
involving other pesticide classes.
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